AMERICAN DIABETES ASSOCIATION INC: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization: AMERICAN DIABETES ASSOCIATION INC (EIN 13-1623888)
Tax period: 2022-01-01 to 2022-12-31
Filed: 2023-09-29
IRS object ID: 202312729349300731
Schema version: 2022v5.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule G
Schedule I
Schedule J
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2023-09-29T03:41:36-00:00	ReturnTs
Tax Period End	2022-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	135381590	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	BDO USA	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	8401 Greensboro Drive Suite 800	AddressLine1Txt
City	McLean	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2022-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	131623888	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	American Diabetes Association	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	AMER	BusinessNameControlTxt
Phone	7035491500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2451 Crystal Drive Suite 900	AddressLine1Txt
City	Arlington	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22202	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	Charlotte M Carter	PersonNm
Person Title	Chief Financial Administrative Offi	PersonTitleTxt
Phone	7035491500	PhoneNum
Signature	2023-09-29	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

Field	Value	IRS element (for citing)
Person First	Charlotte	PersonFirstNm
Person Last	Carter	PersonLastNm

Field	Value	IRS element (for citing)
SSN	XXX-XX-XXXX	SSN

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Marc Berger	PreparerPersonNm
PTIN	P01871563	PTIN
Phone	7038930600	PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	2	TrustedCustomerCd
Authentication Assurance Level	AAL1	AuthenticationAssuranceLevelCd
Identity Assurance Level	IAL1	IdentityAssuranceLevelCd

Field	Value	IRS element (for citing)
Tax	2022	TaxYr
Build TS	2023-04-26 12:10:37Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	Charles D Henderson	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2451 Crystal Dr Suite 900	AddressLine1Txt
City	Arlington	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22202	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$122,866,708	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	www.diabetes.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1940	FormationYr
Legal Domicile State	OH	LegalDomicileStateCd
Activity Or Mission	The mission of the American Diabetes Association the Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.	ActivityOrMissionDesc
Voting Members Governing Body	13	VotingMembersGoverningBodyCnt
Voting Members Independent	13	VotingMembersIndependentCnt
Total Employee	394	TotalEmployeeCnt
Total Volunteers	7910	TotalVolunteersCnt
Total Gross UBI	$805,283	TotalGrossUBIAmt
PY Contributions Grants	$113,184,567	PYContributionsGrantsAmt
CY Contributions Grants	$93,952,438	CYContributionsGrantsAmt
PY Program Service Revenue	$16,969,473	PYProgramServiceRevenueAmt
CY Program Service Revenue	$19,576,892	CYProgramServiceRevenueAmt
PY Investment Income	$2,309,537	PYInvestmentIncomeAmt
CY Investment Income	$495,586	CYInvestmentIncomeAmt
PY Other Revenue	$5,702,144	PYOtherRevenueAmt
CY Other Revenue	$5,117,087	CYOtherRevenueAmt
PY Total Revenue	$138,165,721	PYTotalRevenueAmt
CY Total Revenue	$119,142,003	CYTotalRevenueAmt
PY Grants And Similar Paid	$8,161,453	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$23,200,708	CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$30,224,262	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$35,639,110	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$585,277	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$629,915	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$18,124,878	CYTotalFundraisingExpenseAmt
PY Other Expenses	$42,841,703	PYOtherExpensesAmt
CY Other Expenses	$53,104,745	CYOtherExpensesAmt
PY Total Expenses	$81,812,695	PYTotalExpensesAmt
CY Total Expenses	$112,574,478	CYTotalExpensesAmt
PY Revenues Less Expenses	$56,353,026	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$6,567,525	CYRevenuesLessExpensesAmt
Total Assets BOY	$186,412,830	TotalAssetsBOYAmt
Total Assets EOY	$213,679,073	TotalAssetsEOYAmt
Total Liabilities BOY	$29,672,159	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$56,658,901	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$156,740,671	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$157,020,172	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$39,781,741	ExpenseAmt
Grant	$923,963	GrantAmt
Revenue	$10,290,031	RevenueAmt
Desc	Information - See Schedule O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$14,319,220	ExpenseAmt
Grant	$3,989	GrantAmt
Desc	Advocacy and Public Awareness - See Schedule O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$32,637,257	ExpenseAmt
Grant	$22,272,756	GrantAmt
Revenue	$10,768,198	RevenueAmt
Desc	Research - See Schedule O	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Revenue	$1,881,739	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$86,738,218	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	Yes (true)	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (true)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (true)	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	Yes (true)	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	false	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	false	TaxExemptBondsInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	Yes (true)	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	Yes (true)	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	Yes (true)	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	784	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	394	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Form8899 Filedind	false	Form8899Filedind
Form1098 C Filed	Yes (true)	Form1098CFiledInd
DAF Excess Business Holdings	false	DAFExcessBusinessHoldingsInd
Taxable Distributions	false	TaxableDistributionsInd
Distribution To Donor	false	DistributionToDonorInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	false	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	13	GoverningBodyVotingMembersCnt
Independent Voting Member	13	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (true)	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	Yes (true)	LocalChaptersInd
Policies Reference Chapters	Yes (true)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	Charlotte M Carter CFAO	PersonNm
Phone	7035491500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2451 Crystal Drive Suite 900	AddressLine1Txt
City	Arlington	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22202	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd
Charles D Henderson Effective May 1
Chief Executive Officer	037.00	000.50	Yes (X)	$610,335	$0	$195,079
Robert A Gabbay
Chief Scientific Medical Officer	037.50			$579,883	$0	$69,031	Yes (X)
Charlotte M Carter
Chief Financial Administrative Officer	037.00	000.50	Yes (X)	$390,761	$0	$42,398
Sean C McDonough
Senior Vice President General Counsel	037.50			$228,497	$0	$23,304		Yes (X)
Alana Seger
SVP Field Revenue Operations	037.50			$188,127	$0	$37,348	Yes (X)
Lisa A Murdock
Chief Advocacy Officer	037.50			$192,840	$0	$23,195		Yes (X)
Kelly A Mueller
Senior Vice President, Strategy	037.50			$197,406	$0	$9,421		Yes (X)
Nuha El Sayed
Vice President, Health Care Improvement	037.50			$202,489	$0	$2,009		Yes (X)
Laura B Hieronymus
Vice President, Health Care Programs	037.50			$192,033	$0	$11,343		Yes (X)
Christopher K Ralston JD
Chair of the Board	006.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Guillermo Umpierrez MD CDE
President, Medicine Science	006.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Otis W Kirksey PharmD RPh CDE BC-AD
President, Health Care Education	006.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Marshall Case
Secretary-Treasurer	006.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Rone Luczynski
Chair of the Board-Elect	002.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Rodica Pop-Busui MD PhD
President-Elect, Medicine Science	002.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Janet Brown-Friday RN MSN MPH
President-Elect, Health Care Education	002.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Todd F Brown PMP
Secretary/Treasurer-Elect	002.00	000.20	Yes (X)	$0	$0	$0			Yes (X)
Mandeep Bajaj MBBS
Board of Directors	001.00			$0	$0	$0			Yes (X)
Amparo Gonzalez MPH RN CDE FAADE
Board of Directors	001.00			$0	$0	$0			Yes (X)
Rhodes B Ritenour JD
Board of Directors	001.00			$0	$0	$0			Yes (X)
Stephanie E Silverman MBA Through J
Board of Directors	001.00			$0	$0	$0			Yes (X)
Ruth Weinstock MD PhD
Board of Directors	001.00			$0	$0	$0			Yes (X)
Robin Richardson Effective June 4 2
Board of Directors	001.00			$0	$0	$0			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$2,782,371	TotalReportableCompFromOrgAmt
Total Other Compensation	$413,128	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	82	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
BOATHOUSE GROUP INC
260 Charles Street 4th Floor	Waltham	MA	02453	Marketing and Communications	$1,077,875
VENN STRATEGIES
1341 G Street NW 6th Floor	Washington	DC	20005	Consulting	$973,803
PROSONO LLC
1120 Lincoln St Suite 704	Denver	CO	80203	Project Management Services	$865,168
BLACKBAUD INC
11501 Domain Drive Suite 220	Austin	TX	78758	Constituent Records Application Technical Services	$460,729
CHAPMAN CUBINE ALLEN & HUSSEY INC
2000 N 15th Street Suite 550	Arlington	VA	22201	Fundraising Counsel	$424,800

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	28	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$2,103,543	FederatedCampaignsAmt
Fundraising	$8,780,964	FundraisingAmt
Government Grants	$1,566,205	GovernmentGrantsAmt
All Other Contributions	$81,501,726	AllOtherContributionsAmt
Noncash Contributions	$4,040,659	NoncashContributionsAmt
Total Contributions	$93,952,438	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	ExclusionExclusionAmt
Subscriptions	511120	$6,690,226	$6,690,226
Registration	611710	$7,895,097	$7,895,097
Sales of Material	511130	$533,043	$533,043
Booth Rental	611710	$3,480,289		$3,480,289
Other Program Service Revenue	900099	$978,237	$978,237

Field	Value	IRS element (for citing)
Total Program Service Revenue	$19,576,892	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,748,594	TotalRevenueColumnAmt
Exclusion	$1,748,594	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,754,011	TotalRevenueColumnAmt
Exclusion	$1,754,011	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$908,987	SecuritiesAmt
Other	$47,048	OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$2,157,015	SecuritiesAmt
Other	$52,028	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	-$1,248,028	SecuritiesAmt
Other	-$4,980	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$1,253,008	TotalRevenueColumnAmt
Exclusion	-$1,253,008	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$1,515,662	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$8,780,964	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$1,515,662	FundraisingDirectExpensesAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
Advertising Income	541800	$800,815	$800,815
Catalog Sales Income - Gift of Hope	454110	$4,468	$4,468
Abstract Fees Permissions Income	900099	$625,608		$625,608

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,932,185	TotalRevenueColumnAmt
Related Or Exempt Func Income	$1,932,185	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$3,363,076	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$119,142,003	TotalRevenueColumnAmt
Related Or Exempt Func Income	$18,654,396	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$805,283	UnrelatedBusinessRevenueAmt
Exclusion	$5,729,886	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$23,151,755	TotalAmt
Program Services	$23,151,755	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$48,953	TotalAmt
Program Services	$48,953	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$3,195,498	TotalAmt
Program Services	$2,091,137	ProgramServicesAmt
Management And General	$416,126	ManagementAndGeneralAmt
Fundraising	$688,235	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$25,981,975	TotalAmt
Program Services	$16,998,826	ProgramServicesAmt
Management And General	$3,376,810	ManagementAndGeneralAmt
Fundraising	$5,606,339	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$218,929	TotalAmt
Program Services	$144,096	ProgramServicesAmt
Management And General	$27,795	ManagementAndGeneralAmt
Fundraising	$47,038	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$4,104,750	TotalAmt
Program Services	$2,646,530	ProgramServicesAmt
Management And General	$619,280	ManagementAndGeneralAmt
Fundraising	$838,940	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$2,137,958	TotalAmt
Program Services	$1,401,238	ProgramServicesAmt
Management And General	$268,832	ManagementAndGeneralAmt
Fundraising	$467,888	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$230,250	TotalAmt
Program Services	$30,340	ProgramServicesAmt
Management And General	$186,481	ManagementAndGeneralAmt
Fundraising	$13,429	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$256,495	TotalAmt
Program Services	$5,131	ProgramServicesAmt
Management And General	$250,082	ManagementAndGeneralAmt
Fundraising	$1,282	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$254,876	TotalAmt
Program Services	$254,876	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$629,915	TotalAmt
Fundraising	$629,915	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$209,874	TotalAmt
Management And General	$209,874	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$16,650,591	TotalAmt
Program Services	$14,838,297	ProgramServicesAmt
Management And General	$588,507	ManagementAndGeneralAmt
Fundraising	$1,223,787	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$4,794,457	TotalAmt
Program Services	$2,069,431	ProgramServicesAmt
Management And General	$4,388	ManagementAndGeneralAmt
Fundraising	$2,720,638	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$1,043,192	TotalAmt
Program Services	$630,733	ProgramServicesAmt
Management And General	$195,473	ManagementAndGeneralAmt
Fundraising	$216,986	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$3,518,167	TotalAmt
Program Services	$2,320,413	ProgramServicesAmt
Management And General	$341,822	ManagementAndGeneralAmt
Fundraising	$855,932	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$27,554	TotalAmt
Program Services	$27,482	ProgramServicesAmt
Fundraising	$72	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$4,863,388	TotalAmt
Program Services	$3,648,715	ProgramServicesAmt
Management And General	$436,263	ManagementAndGeneralAmt
Fundraising	$778,410	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$943,156	TotalAmt
Program Services	$758,041	ProgramServicesAmt
Management And General	$55,610	ManagementAndGeneralAmt
Fundraising	$129,505	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$5,862,252	TotalAmt
Program Services	$5,831,966	ProgramServicesAmt
Management And General	$2,525	ManagementAndGeneralAmt
Fundraising	$27,761	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$35	TotalAmt
Program Services	$9	ProgramServicesAmt
Management And General	$5	ManagementAndGeneralAmt
Fundraising	$21	FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$2,213,675	TotalAmt
Program Services	$1,438,889	ProgramServicesAmt
Management And General	$287,778	ManagementAndGeneralAmt
Fundraising	$487,008	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$375,694	TotalAmt
Program Services	$271,077	ProgramServicesAmt
Management And General	$38,814	ManagementAndGeneralAmt
Fundraising	$65,803	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
Supplies	$2,539,491	$2,473,763	$22,373	$43,355
Postage and Shipping	$1,901,810	$779,994	$11,382	$1,110,434
Printing and Publications	$3,974,793	$2,580,462	$20,568	$1,373,763
Data Processing	$3,387,620	$2,274,261	$330,513	$782,846

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$57,375	TotalAmt
Program Services	$21,803	ProgramServicesAmt
Management And General	$20,081	ManagementAndGeneralAmt
Fundraising	$15,491	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$112,574,478	TotalAmt
Program Services	$86,738,218	ProgramServicesAmt
Management And General	$7,711,382	ManagementAndGeneralAmt
Fundraising	$18,124,878	FundraisingAmt

Field	Value	IRS element (for citing)
Joint Costs	Yes (X)	JointCostsInd

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$10,477,505	TotalAmt
Program Services	$2,198,410	ProgramServicesAmt
Management And General	$99,003	ManagementAndGeneralAmt
Fundraising	$8,180,092	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$874,746	BOYAmt
EOY	$216,475	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$39,642,647	BOYAmt
EOY	$60,857,512	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$54,877,293	BOYAmt
EOY	$52,564,508	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$1,464,766	BOYAmt
EOY	$1,262,632	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$296,086	BOYAmt
EOY	$336,906	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$2,248,439	BOYAmt
EOY	$3,147,397	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$27,247,020	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$23,007,124	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$5,587,220	BOYAmt
EOY	$4,239,896	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$49,367,410	BOYAmt
EOY	$44,330,366	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$12,516,775	BOYAmt
EOY	$11,104,921	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$19,537,448	BOYAmt
EOY	$35,618,460	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$186,412,830	BOYAmt
EOY	$213,679,073	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$18,310,089	BOYAmt
EOY	$8,070,665	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$3,903,387	BOYAmt
EOY	$15,768,715	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$7,458,683	BOYAmt
EOY	$5,613,331	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
EOY	$27,206,190	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$29,672,159	BOYAmt
EOY	$56,658,901	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$58,558,684	BOYAmt
EOY	$53,866,582	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$98,181,987	BOYAmt
EOY	$103,153,590	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$156,740,671	BOYAmt
EOY	$157,020,172	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$186,412,830	BOYAmt
EOY	$213,679,073	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$6,567,525	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$7,369,583	NetUnrlzdGainsLossesInvstAmt
Prior Period Adjustments	$305	PriorPeriodAdjustmentsAmt
Other Changes In Net Assets	$1,081,254	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$118,306,745	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$108,955,331	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$88,149,776	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$113,184,567	CurrentTaxYearMinus1YearAmt
Current Tax Year	$93,952,438	CurrentTaxYearAmt
Total	$522,548,857	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$118,306,745	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$108,955,331	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$88,149,776	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$113,184,567	CurrentTaxYearMinus1YearAmt
Current Tax Year	$93,952,438	CurrentTaxYearAmt
Total	$522,548,857	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$34,043,883	SubstantialContributorsTotAmt
Public Support Total170	$488,504,974	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$4,492,015	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$3,352,336	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$2,566,585	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$3,236,138	CurrentTaxYearMinus1YearAmt
Current Tax Year	$3,502,605	CurrentTaxYearAmt
Total	$17,149,679	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,730	CurrentTaxYearMinus4YearsAmt
Total	$2,730	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$539,701,266	TotalSupportAmt
Gross Receipts Rltd Activities	$140,505,347	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.90510	PublicSupportCY170Pct
Public Support PY170	0.91260	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	Yes (true)	VolunteersInd
Paid Staff Or Management	Yes (true)	PaidStaffOrManagementInd
Media Advertisements	Yes (true)	MediaAdvertisementsInd
Media Advertisements	$150,000	MediaAdvertisementsAmt
Mailings Members	Yes (true)	MailingsMembersInd
Mailings Members	$48,683	MailingsMembersAmt
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	false	GrantsOtherOrganizationsInd
Direct Contact Legislators	Yes (true)	DirectContactLegislatorsInd
Direct Contact Legislators	$390,958	DirectContactLegislatorsAmt
Rallies Demonstrations	Yes (true)	RalliesDemonstrationsInd
Rallies Demonstrations	$23,660	RalliesDemonstrationsAmt
Other Activities	false	OtherActivitiesInd
Total Lobbying Expenditures	$613,301	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

II-B

The American Diabetes Associations advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Raising our voices from Capitol Hill to state legislatures across the country, our dedicated Diabetes Advocates continue to drive momentum in our ongoing fight to stop diabetes. Our advocacy work gives people with diabetes, their families and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state and national levels. Our advocacy priorities include Increasing federal and state funding for diabetes prevention, treatment, and research. Improving access to adequate and affordable health care. Ending discrimination people with diabetes face at school, work and elsewhere in their lives. Achieving health equity. Addressing health disparities people with diabetes face during the COVID19 pandemic. In 2022, the ADA achieved Increased funding for the National Institute of Diabetes and Digestive and Kidney Diseases from 2.204 billion in FY2022 to 2.300 billion in FY2023, increased funding for the Centers for Disease Control and Prevention Division of Diabetes from 153.1 million in FY2022 to 155.1 million in FY2023 and increased funding for the National Diabetes Prevention Program from 34.3 million in FY2022 to 37.3 million in FY2023, and funding for the Advanced Research Projects Agency for Health 1.500 billion 50 increase over FY2022.

II-B

Participated in hundreds of meetings, briefings events and other actions in support of our advocacy priorities which led to 130 legislative and regulatory wins at the state and federal levels. Hosted a Roundtable discussion on promoting clinical trial diversity for people with diabetes. The roundtable brought together key stakeholders in diabetes advocacy, industry, and government who pinpointed best practices, reviewed current clinical diversity recommendations and policies, and developed consensus recommendations aimed at advancing best practices and policy changes leading to increased diversity in diabetes-focused clinical trials. Supported the passage of the first ever, national co pay cap for insulin in the Inflation Reduction Act. Educated and inspired action among our 500,000 advocates about state and legal advocacy through calls to action and updates throughout the year. Improved access to continuous glucose monitors for Medicare beneficiaries and Medicaid beneficiaries in more than ten states. Increased access to nutritious foods through increased funding for SNAP benefits, healthy food financing, school based meal assistance programs, and other state level health equity legislation that impacts communities across the country. Published guidance and resources for parents and school personnel on diabetes management in the school setting and published a new tool, the Diabetes Medical Management Plan for use by schools and pediatric diabetes health care providers nationwide. The new tool allowed for more standardized, efficient completion of student diabetes care orders. Launched the Amputation Prevention Alliance, a group of stakeholders united against the rising rates of diabetes related amputations. The APA published policy priorities, convened a clinical advisory working group, and hosted several events aimed at raising awareness and support for necessary policy changes aimed at reducing the rate of diabetes related amputations.

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Donor Advised Funds Held	1	DonorAdvisedFundsHeldCnt
Donor Advised Funds Vl EOY	$712,516	DonorAdvisedFundsVlEOYAmt
Disclosed Org Leg Ctrl	Yes (true)	DisclosedOrgLegCtrlInd
Disclosed For Charitable Prps	Yes (true)	DisclosedForCharitablePrpsInd
Incl Escrow Custodial Acct Liab	false	InclEscrowCustodialAcctLiabInd

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$22,804,536	BeginningYearBalanceAmt
Investment Earnings Or Losses	$386,389	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$1,754,951	GrantsOrScholarshipsAmt
End Year Balance	$21,435,974	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$23,164,825	BeginningYearBalanceAmt
Contributions	-$5,530	ContributionsAmt
Investment Earnings Or Losses	$2,154,099	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,508,858	GrantsOrScholarshipsAmt
End Year Balance	$22,804,536	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$23,451,734	BeginningYearBalanceAmt
Contributions	$371	ContributionsAmt
Investment Earnings Or Losses	$2,318,586	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,605,866	GrantsOrScholarshipsAmt
End Year Balance	$23,164,825	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$22,635,671	BeginningYearBalanceAmt
Contributions	$80,442	ContributionsAmt
Investment Earnings Or Losses	$2,949,834	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,214,213	GrantsOrScholarshipsAmt
End Year Balance	$23,451,734	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$22,899,249	BeginningYearBalanceAmt
Contributions	$4,547	ContributionsAmt
Investment Earnings Or Losses	$1,449,845	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$1,717,970	GrantsOrScholarshipsAmt
End Year Balance	$22,635,671	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	0.19000	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.81000	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	Yes (true)	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$4,500	OtherCostOrOtherBasisAmt
Book Value	$4,500	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$5,826,966	OtherCostOrOtherBasisAmt
Depreciation	$3,538,042	DepreciationAmt
Book Value	$2,288,924	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$8,048,428	OtherCostOrOtherBasisAmt
Depreciation	$7,252,888	DepreciationAmt
Book Value	$795,540	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$13,367,126	OtherCostOrOtherBasisAmt
Depreciation	$12,216,194	DepreciationAmt
Book Value	$1,150,932	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$4,239,896	TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (3 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
Financial derivatives and other financial products
Closely-held equity interests
Perpetual Trusts	$11,104,921	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$11,104,921	TotalBookValueSecuritiesAmt

Other Assets Org OtherAssetsOrgGrp (3 entries)

DescDesc	Book ValueBookValueAmt
Due From Property Title Holding Corporation	$6,856,343
Investment in Net Assets of American Diabetes Association Property Title Holding Corporation	$12,817,875
Right-of-Use Assets - Operating Leases	$15,944,242

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$35,618,460	TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)

DescDesc	AmtAmt
Federal income taxes
Due to American Diabetes Association Property Title Holding Corporation	$57,375
Lease Liabilities - Operating Leases	$27,148,815

Field	Value	IRS element (for citing)
Total Liability	$27,206,190	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
V 4	The following was disclosed in the consolidated financial statements related to the intended use of the ADA endowment funds The ADA has adopted an investment policy for endowment assets that provides continued financial stability for the ADA and a revenue stream for spending on the ADA mission.
V 4	To fulfill this mission, the American Diabetes Association funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals, and the public.
X 2	The following was disclosed related to uncertain tax positions in the audited financial statements The American Diabetes Association is generally exempt from income taxes under Section 501c3 of the Internal Revenue Code the Code and charitable contributions to these organizations qualify for tax deductions as described in the Code. PTHC is generally exempt from income taxes under Section 501c2 of the Code. These entities are subject to taxation on any net unrelated business income and have been classified as organizations that are not private foundations under Section 509a of the Code. ADA recognizes the effect of income tax positions only if those positions more likely than not would not be sustained upon examination by the Internal Revenue Service. ADA has analyzed the tax positions taken and has concluded that as of December 31, 2022, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liablility or asset or disclosure in the consolidated financial statements. ADA is open to examination by taxing authorities for the years ended December 31, 2019 and forward.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
Chapman Cubine Allen & Hussey Inc
2000 N 15th Street	Arlington	VA	22201	See Part IV	false	$9,167,860	$566,400	$8,601,460
Charitable Adult Rides & Services Inc
4669 Murphy Canyon Road Suite 200	San Diego	CA	92123	See Part IV	Yes (true)	$657,200	$193,871	$463,329
Forward PMX
One World Trade Center 63rd Floor	New York	NY	10007	See Part IV	false	$1,475,612	$325,742	$1,149,870
GoodUnited Inc
796 Meeting Street	Charleston	SC	29403	See Part IV	false	$1,262,829	$89,743	$1,173,086

Field	Value	IRS element (for citing)
Total Gross Receipts	$12,563,501	TotalGrossReceiptsAmt
Total Retained By Contractors	$1,175,756	TotalRetainedByContractorsAmt
Total Net To Organization	$11,387,745	TotalNetToOrganizationAmt
Licensed States	AK	LicensedStatesCd
Licensed States	AL	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	DE	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MT	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WY	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	Step Out	Event1Nm
Gross Receipts Event1	$1,662,377	GrossReceiptsEvent1Amt
Charitable Contri Event1	$1,400,457	CharitableContriEvent1Amt
Gross Revenue Event1	$261,920	GrossRevenueEvent1Amt
Non Cash Prizes Event1	$32,323	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$140,034	RentFacilityCostsEvent1Amt
Other Direct Expenses Event1	$89,563	OtherDirectExpensesEvent1Amt
Event2	Tour de Cure	Event2Nm
Gross Receipts Event2	$5,789,817	GrossReceiptsEvent2Amt
Charitable Contri Event2	$4,938,108	CharitableContriEvent2Amt
Gross Revenue Event2	$851,709	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$207,056	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$296,749	RentFacilityCostsEvent2Amt
Other Direct Expenses Event2	$347,904	OtherDirectExpensesEvent2Amt
Other Events Total	1	OtherEventsTotalCnt
Gross Receipts Other Events	$2,844,432	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$2,442,399	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$402,033	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$21,034	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$249,364	RentFcltyCostsOtherEventsAmt
Oth Direct Expnss Other Events	$131,635	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$10,296,626	GrossReceiptsTotalAmt
Charitable Contributions Tot	$8,780,964	CharitableContributionsTotAmt
Gross Revenue Total Events	$1,515,662	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$260,413	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$686,147	RentFcltyCostsTotalEventsAmt
Oth Direct Expnss Total Events	$569,102	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$1,515,662	DirectExpenseSummaryEventsAmt

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 2b1	Chapman Cubine Allen Hussey, Inc. activities are strategic services including account and project management, data processing analysis and reporting, meeting, and/or project services requested by ADA.
Part I Line 2b2	Charitable Adult Rides Services, Inc. activities are advertising, acquisition and disposal of donated vehicles solicited by American Diabetes Association.
Part I Line 2b2	Upon sale of the donated vehicle, the funds are deposited into the Charitable Adult Rides Services, Inc. bank account. The net proceeds from the donated car are then sent by Charitable Adult Rides Services, Inc. to the American Diabetes Association bank account.
Part I Line 2b3	Forward PMX activities are to provide program strategy and media management through various media channels to drive fundraising revenue for the ADAs direct response fundraising program.
Part I Line 2b4	GoodUnited, Inc. activities are to help ADA find and engage with supporters on social media in the channel where they spend time.

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (149 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
American Academy of Physician Associates
2318 Mill Road Suite 1300	Alexandria	VA	22314	237067770	501 c6	$20,000	Education and Development
American Association of Nurse Practitioners
5901 Vega Avenue Suite 200	Austin	TX	78735	222547543	501 c6	$30,000	Education and Development
American Pharmacists Association Foundation
2215 Constitution Avenue NW	Washington	DC	20037	526039142	501 c3	$50,000	Education and Development
American Society of Health-System Pharmacists
4500 East-West Highway Suite 900	Bethesda	MD	20814	520807628	501 c3	$30,000	Education and Development
Association of Diabetes Care & Education Specialists
125 South Wacker Drive Suite 600	Chicago	IL	60606	510161670	501 c6	$20,000	Education and Development
Diabetes Education and Camping Association
12557 New Brittany Boulevard	Fort Myers	FL	33907	631187548	501 c3	$5,000	Education and Development
Garland Independent School District
501 South Jupiter	Garland	TX	75042	756001650		$42,000	Education and Development
Health Resources In Action Inc
2 Boylston Street 4th Floor	Boston	MA	02116	042229839	501 c3	$100,000	Education and Development
Ochsner Clinic Foundation
1514 Jefferson Highway	New Orleans	LA	70121	720502505	501 c3	$5,500	Education and Development
Profit Financial Group
314 Comiskey Park Circle	Summerville	SC	29485	832014629		$12,700	Education and Development
T-1 Today Inc
8216 Princeton-Glendale Road Suite	West Chester	OH	45069	463704802	501 c3	$80,000	Education and Development
Taking Control of Your Diabetes
990 Highland Drive Suite 312	Solana Beach	CA	92075	330794608	501 c3	$37,000	Education and Development
Temple Center for Population Health LLC
3509 North Broad Street	Philadelphia	PA	19140	232825881	501 c3	$45,000	Education and Development
Top Box Foods
222 West Merchandise Mart Plaza	Chicago	IL	60654	453930886	501 c3	$14,000	Education and Development
United Clergy Task Force Inc
209 Plains Drive	Burlington	NC	27217	475459058	501 c3	$6,000	Education and Development
Urban Community Health and Wellness
5924 Victoria Park Way	North Chesterfield	VA	23234	871306059	170b1	$6,500	Education and Development
University of Connecticut School of Nursing
231 Glenbrook Road	Storrs	CT	06269	060772160	115	$200,000	Innovative Clinical or Translational Science New Health Disparities
University of Washington
1201 Larimer Street	Seattle	WA	99164	916001108	501c3	$200,000	Innovative Clinical or Translational Science New Health Disparities
Indiana University
PO Box 500	Bloomington	IN	47402	356018940	501c3	$200,000	Innovative Clinical or Translational Science New Health Disparities
University of Colorado
1800 Grant Street Suite 600	Denver	CO	80203	846000555	501c3	$200,000	Innovative Clinical/Translational Science Nutrition
New York University School of Medicine
550 First Avenue	New York	NY	10016	135562308	501c3	$200,000	Innovative Clinical/Translational Science Nutrition
University of Utah
201 South Presidents Circle Rm 406	Salt Lake City	UT	84112	876000525	501c3	$200,000	Innovative Clinical/Translational Science Nutrition
University of Colorado
1800 Grant Street Suite 600	Denver	CO	80203	846000555	501c3	$200,000	Innovative Clinical/Translational Science Precision Medicine
University of Virginia
1001 North Emmet Street	Charlottesville	VA	22904	546001796	501c3	$200,000	Innovative Clinical/Translational Science Precision Medicine
Partners Healthcare System Inc
399 Revolution Dr Ste 645	Somerville	MA	021451465	042103561	501c3	$200,000	Innovative Clinical/Translational Science Precision Medicine
University of Utah
201 South Presidents Circle Rm 406	Salt Lake City	UT	84112	876000525	501c3	$200,000	Innovative Clinical/Translational Science Precision Medicine
University of Colorado Anschutz Medical Campus
13001 East 17th Place	Aurora	CO	80045	846000555	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
University of Utah
201 South Presidents Circle Rm 406	Salt Lake City	UT	84112	876000525	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
University of California San Francisco
3333 California Street Ste 315	San Francisco	CA	910103012	953432210	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
Stanford University
3145 Porter Drive	Palo Alto	CA	93407	204927897	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
Clemson University
391 College Avenue Suite 301	Clemson	SC	29634	576000254	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
University of North Carolina at Chapel Hill
104 Airport Dr Ste 2200 CD1350	Chapel Hill	NC	27157	223849199	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
Childrens Hospital Los Angeles
4650 Sunset Boulevard	Los Angeles	CA	90027	951690977	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
Michigan State University
426 Auditorium Road	East Lansing	MI	48824	386005984	501c3	$200,000	Innovative Clinical or Translational Science Nutrition
Eastern Virginia Medical School
PO Box 1980	Norfolk	VA	23501	546055378	501c3	$199,999	Innovative Clinical or Translational Science Nutrition
University of Michigan
3003 S State St Rm 1054	Ann Arbor	MI	48202	386028429	501c3	$199,999	Innovative Clinical or Translational Science Nutrition
President and Fellows of Harvard College
1033 Massachusetts Ave Third Floor	Cambridge	MA	01655	043167352	115	$199,999	Innovative Clinical or Translational Science Nutrition
Denver Health and Hospital Authority
655 Broadway	Denver	CO	80203	841343242	501c3	$199,998	Innovative Clinical/Translational Science Nutrition
The Regents of the University of Michigan
3003 South State Street	Ann Arbor	MI	48109	386028429	501c3	$199,998	Innovative Clinical or Translational Science Health Disparities
Broad Institute Inc
415 Main Street	Cambridge	MA	02142	263428781	501c3	$199,989	Innovative Clinical or Translational Science Health Disparities
George Washington University
1922 F Street NW 4th Floor	Washington	DC	20052	530196584	501c3	$199,984	Innovative Clinical or Translational Science New Health Disparities
Regents of the University of California
1111 Franklin Street 10th Floor	Oakland	CA	92093	956006144	501c3	$199,973	Innovative Clinical or Translational Science Health Disparities
Children's Hospital Corporation
301 Longwood Ave	Boston	MA	01655	043167352	115	$199,973	Innovative Clinical or Translational Science Health Disparities
Gretchen Swanson Center for Nutrition
505 Durham Research Plaza	Omaha	NE	68105	237175802	501c3	$199,926	Innovative Clinical/Translational Science Nutrition
University of North Carolina at Chapel Hill
104 Airport Dr Ste 2200 CD1350	Chapel Hill	NC	27157	223849199	501c3	$199,877	Innovative Clinical or Translational Science New Health Disparities
Kaiser Permanente Northern California
One Kaiser Plaza	Oakland	CA	94612	941340523	501c3	$199,818	Innovative Clinical or Translational Science New Health Disparities
Northwestern University Medical School
420 East Superior Street	Chicago	IL	60611	362167817	501c3	$199,801	Innovative Clinical or Translational Science Health Disparities
University of Tennessee
1331 Circle Park Drive	Knoxville	TN	37916	626001636	170c1	$199,783	Innovative Clinical or Translational Science Health Disparities
University of Kentucky Research Foundation
301 Peterson Service Building	Lexington	KY	40506	616033693	501c3	$199,642	Innovative Clinical or Translational Science Health Disparities
Connecticut Children's Medical Center Foundation
282 Washington Street	Hartford	CT	06106	222619869	501c3	$199,628	Innovative Clinical or Translational Science Health Disparities
University of Texas Southwestern Medical Center at Dallas
PO Box 841753	Dallas	TX	77840	742245072	501c3	$199,513	Innovative Clinical or Translational Science Health Disparities
Ohio State University
1960 Kenny Road	Columbus	OH	45701	316402269	501c3	$199,189	Innovative Clinical or Translational Science Health Disparities
University of Colorado Anschutz Medical Campus
13001 East 17th Place	Aurora	CO	80045	846000555	501c3	$199,143	Innovative Clinical or Translational Science Health Disparities
Colorado School of Public Health
13001 East 17th Place	Aurora	CO	80045	846000555	501c3	$198,496	Innovative Clinical/Translational Science Precision Medicine
Wake Forest University Health Sciences
Medical Center Boulevard	WinstonSalem	NC	27157	223849199	501c3	$198,362	Innovative Clinical or Translational Science Nutrition
University of Utah
201 South Presidents Circle Rm 406	Salt Lake City	UT	84112	876000525	501c3	$197,495	Innovative Clinical or Translational Science Nutrition
Partners Healthcare System Inc
399 Revolution Dr Ste 645	Somerville	MA	021451465	042103561	501c3	$196,859	Innovative Clinical or Translational Science Nutrition
University of Chicago
5801 South Ellis Avenue	Chicago	IL	60637	362177139	501c3	$196,259	Innovative Clinical/Translational Science Precision Medicine
The Board of Regents of the University of Wisconsin System
21 N Park Street Suite 6401	Madison	WI	53226	390806261	501c3	$194,500	Innovative Clinical or Translational Science New Health Disparities
Ann and Robert H Lurie Children's Hospital of Chicago
225 E Chicago Ave	Chicago	IL	60611	362170833	501c3	$177,976	Innovative Clinical or Translational Science New Health Disparities
Georgia Institute of Technology
500 Tech Parkway NW	Atlanta	GA	30332	586002023	501c3	$174,996	Innovative Clinical or Translational Science Health Disparities
University of North Carolina at Chapel Hill
104 Airport Dr Ste 2200 CD1350	Chapel Hill	NC	27157	223849199	501c3	$164,614	Junior Faculty Development
University of Michigan
3003 S State St Rm 1054	Ann Arbor	MI	48202	386028429	501c3	$138,000	Junior Faculty
University of Iowa
4 Jessup Hall Room B5	Iowa City	IA	52242	426004813	115	$138,000	Junior Faculty
Indiana University
PO Box 500	Bloomington	IN	47402	356018940	501c3	$138,000	Junior Faculty
Florida State University Research Foundation Inc
2000 Levy Avenue	Tallahassee	FL	32310	593211153	501c3	$138,000	Junior Faculty Development Precision Medicine
City of Hope Beckman Research Institute
1500 East Duarte Road	Duarte	CA	94305	941156365	501c3	$138,000	Junior Faculty Development
Georgia State University Research Foundation Inc
33 Gilmer Street SE	Atlanta	GA	30303	581845423	501c3	$138,000	Junior Faculty Development
Beckman Research Institute of City of Hope
1500 East Duarte Road	Duarte	CA	94305	941156365	501c3	$138,000	Junior Faculty Development
University of Miami
1252 Memorial Drive	Coral Gables	FL	33146	590624458	501c3	$137,999	Junior Faculty Development Precision Medicine
Medical College of Wisconsin
8701 Watertown Plank Rd	Milwaukee	WI	53226	390806261	501c3	$137,998	Junior Faculty Development Precision Medicine
HealthPartners Institute
8170 33rd Avenue South	Minneapolis	MN	55440	411670163	501c3	$137,997	Junior Faculty Nutrition
University of Cincinnati
51 Goodman Drive	Cincinnati	OH	45221	316000989	501c3	$137,995	Junior Faculty Development Precision Medicine
University of Texas at Austin
601 Colorado Street	Austin	TX	78701	746000203	170c1	$137,995	Junior Faculty Development Precision Medicine
University of Arizona
2700 N Central Ave Suite 850	Phoenix	AZ	85004	742652689	170c1	$137,991	Junior Faculty Development Precision Medicine
University of Kansas Medical Center Research Institute Inc
3901 Rainbow Boulevard	Kansas City	KS	66160	481108830	501c3	$137,989	Junior Faculty Nutrition
University of Florida
903 West University Avenue	Gainesville	FL	32601	596002052	170c1	$137,985	Junior Faculty Precision Medicine
Case Western Reserve University
10900 Euclid Avenue	Cleveland	OH	45701	316402269	501c3	$137,974	Innovative Clinical or Translational Science New Health Disparities
Yale University
155 Whitney Avenue Room 230 PO Box	New Haven	CT	06510	060646973	501c3	$137,874	Junior Faculty Nutrition
Medical College of Wisconsin
8701 Watertown Plank Rd	Milwaukee	WI	53226	390806261	501c3	$137,836	Junior Faculty Development
University of Colorado
1800 Grant Street Suite 600	Denver	CO	80203	846000555	501c3	$137,736	Junior Faculty Development Precision Medicine
University of Wyoming
1000 East University Avenue	Laramie	WY	82071	836000331	501c3	$137,696	Junior Faculty Development Precision Medicine
University of Massachusetts Amherst-Pioneer Valley Life Science Institute
3601 Main Street	Springfield	MA	01001	571183126	501c3	$137,512	Junior Faculty Development Precision Medicine
Partners Healthcare System Inc
399 Revolution Dr Ste 645	Somerville	MA	021451465	042103561	501c3	$134,059	Junior Faculty
University of Colorado Anschutz Medical Campus
13001 East 17th Place	Aurora	CO	80045	846000555	501c3	$131,766	Innovative Clinical or Translational Science Nutrition
Colorado School of Mines
1500 Illinois Street	Golden	CO	80401	846000551	501c3	$128,758	Junior Faculty
Johns Hopkins University School of Medicine
733 North Broadway	Baltimore	MD	21205	520595110	501c3	$115,000	Innovative Basic Science Precision Medicine
Regents of the University of California
1111 Franklin Street 10th Floor	Oakland	CA	92093	956006144	501c3	$115,000	Innovative Basic Science Precision Medicine
Yale University
155 Whitney Avenue Room 230 PO Box	New Haven	CT	06510	060646973	501c3	$115,000	Innovative Basic Science Precision Medicine
University of Washington
1201 Larimer Street	Seattle	WA	99164	916001108	501c3	$115,000	Innovative Basic Science Precision Medicine
University of Massachusetts
333 South St Ste 450	Shrewsbury	MA	02115	042774441	501c3	$115,000	Innovative Basic Science Precision Medicine
University of Washington
1201 Larimer Street	Seattle	WA	99164	916001108	501c3	$115,000	Innovative Basic Science Precision Medicine
Vanderbilt University Medical Center
3319 West End Avenue Ste 800	Nashville	TN	37203	620476822	501c3	$115,000	Innovative Basic Science Precision Medicine
Benaroya Research Institute at Virginia Mason
1201 Ninth Avenue	Seattle	WA	98101	910653422	501c3	$113,417	Innovative Basic Science Precision Medicine
University of Pittsburgh
116 Atwood Street Suite 201	Pittsburg	PA	15261	250965591	501c3	$104,191	Junior Faculty Development
The General Hospital Corporation dba Massachusetts General Hospital
55 Fruit Street	Boston	MA	01655	043167352	115	$75,598	Postdoctoral Fellowship Precision Medicine
Joslin Diabetes Center Inc
One Joslin Place	Boston	MA	01655	043167352	115	$71,308	Mentor-Based Postdoctoral Fellowship
Children's Research Institute
111 Michigan Ave NW	Washington	DC	20010	521654453	501c3	$70,780	Postdoctoral Fellowship Health Disparities Award
Joan & Sanford I Weill Medical College of Cornell University
1300 York Ave	New York	NY	10065	150532082	501c3	$69,780	Postdoctoral Fellowship Precision Medicine
Beth Israel Deaconess Medical Center Inc
330 Brookline Ave	Boston	MA	02115	042774441	501c3	$69,100	Mentor-Based Postdoctoral Fellowship
Baylor College of Medicine
One Baylor Plaza	Houston	TX	75284	756002868	170c1	$67,500	ADA-Pfizer Fellowship Award
Harvard Medical School
1033 Massachusetts Ave Third Floor	Cambridge	MA	01655	043167352	115	$66,880	Mentor-Based Postdoctoral Fellowship
University of Miami School of Medicine
PO Box 025405	Miami	FL	33102	590624458	501c3	$66,712	New Postdoctoral Fellowship
Joan & Sanford I Weill Medical College of Cornell University
1300 York Ave	New York	NY	10065	150532082	501c3	$65,631	Postdoctoral Fellowship Precision Medicine
Stanford University School of Medicine
3145 Porter Drive	Palo Alto	CA	94305	941156365	501c3	$65,227	Postdoctoral Fellowship Precision Medicine
City of Hope Beckman Research Institute
1500 East Duarte Road	Duarte	CA	94305	941156365	501c3	$64,756	Mentor-Based Postdoctoral Fellowship
The Children's Mercy Hospital
2401 Gillham Road	Kansas City	MO	64108	440605373	501c3	$64,144	New Postdoctoral Fellowship
University of Virginia
1001 N Emmet St	Charlottesville	VA	22904	546001796	501c3	$64,142	New Postdoctoral Fellowship
University of North Carolina at Chapel Hill
104 Airport Dr Ste 2200 CD1350	Chapel Hill	NC	27157	223849199	501c3	$63,760	New Postdoctoral Fellowship
Partners Healthcare System Inc
399 Revolution Dr Ste 645	Somerville	MA	021451465	042103561	501c3	$63,760	New Postdoctoral Fellowship
Joan and Sanford I Weill Medical College
1300 York Ave	New York	NY	10065	150532082	501c3	$61,889	Investigator New to Diabetes Research Award
Joslin Diabetes Center Inc
One Joslin Place	Boston	MA	01655	043167352	115	$60,760	Mentor-Based Postdoctoral Fellowship
Board of Regents of the University of Wisconsin System
21 N Park Street Suite 6401	Madison	WI	53226	390806261	501c3	$60,760	Mentor-Based Postdoctoral Fellowship
The General Hospital Corporation dba Massachusetts General Hospital
55 Fruit Street	Boston	MA	01655	043167352	115	$58,533	Postdoctoral Fellowship Precision Medicine
Northwestern University
633 Clark Street	Evanston	IL	60208	362167817	501c3	$55,000	CDTR Award
Kaiser Foundation Research Institute
1800 Harrison Street	Oakland	CA	94612	941105628	501c3	$55,000	CDTR Award
Kaiser Foundation Research Institute
1800 Harrison Street	Oakland	CA	94612	941105628	501c3	$55,000	CDTR Award
University of Michigan
3003 S State St Rm 1054	Ann Arbor	MI	48202	386028429	501c3	$54,880	CDTR Award
Emory University
1599 Clifton Road	Atlanta	GA	30322	580566256	501c3	$54,844	CDTR Award
University of Colorado Denver
1800 Grant Street Suite 600	Denver	CO	80203	846000555	501c3	$54,718	CDTR Award
Albert Einstein College of Medicine
1300 Morris Park Avenue	Bronx	NY	10461	472209056	501c3	$54,704	CDTR Award
Albert Einstein College of Medicine
1300 Morris Park Avenue	Bronx	NY	10461	472209056	501c3	$54,006	CDTR Award
Duke University
324 Blackwell St Washington Bldg	Durham	NC	27599	566001393	501c3	$52,896	ADA-Pfizer Fellowship Award
University of Michigan
3003 S State St Rm 1054	Ann Arbor	MI	48202	386028429	501c3	$49,153	Mentor-Based Minority Postdoctoral Fellowship
University of Colorado Denver
1800 Grant Street Suite 600	Denver	CO	80203	846000555	501c3	$36,693	CDTR Award
George Washington University Biostatistics Center
6110 Executive Blvd	Rockville	MD	20852	530196584	501c3	$33,000	RISE Co-Support
Emory University
1599 Clifton Road	Atlanta	GA	30322	580566256	501c3	$32,870	CDTR Award
University of Kansas Medical Center Research Institute Inc
3901 Rainbow Boulevard	Kansas City	KS	66160	481108830	501c3	$10,000	Loan
Medical College of Wisconsin
8701 Watertown Plank Rd	Milwaukee	WI	53226	390806261	501c3	$10,000	Loan
Arizona Board of Regents University of Arizona
2700 N Central Ave Suite 850	Phoenix	AZ	85004	742652689	170c1	$10,000	Loan
University of Colorado
1800 Grant Street Suite 600	Denver	CO	80203	846000555	501c3	$10,000	Loan
University of Miami
1252 Memorial Drive	Coral Gables	FL	33146	590624458	501c3	$10,000	Loan
Medical College of Wisconsin
8701 Watertown Plank Rd	Milwaukee	WI	53226	390806261	501c3	$10,000	Student Loan
The University of North Carolina at Chapel Hill
104 Airport Dr Ste 2200 CD1350	Chapel Hill	NC	27157	223849199	501c3	$10,000	Student Loan
University of Wyoming
1000 East University Avenue	Laramie	WY	82071	836000331	501c3	$8,000	Loan
Northwestern University Medical School
420 E Superior St 9th Floor	Chicago	IL	60611	362167817	501c3	$1,625,000	Early Investigator Award
University of North Carolina at Chapel Hill
104 Airport Dr Ste 2200 CD1350	Chapel Hill	NC	27157	223849199	501c3	$1,622,683	Early Investigator Award
Indiana University School of Medicine
107 S Indiana Avenue	Bloomington	IN	47405	356001673	501c3	$325,000	Research Career Initiator
Columbia University
615 West 131st Street MC 8741	New York	NY	10065	131924236	501c3	$325,000	Early Investigator Award
University of Illinois at Urbana-Champaign
1305 West Green Street	Urbana	IL	61801	376006007	501c3	$325,000	Investigator New to Diabetes Research Award
Washington University
700 Rosedale Avenue	Saint Louis	MO	631121408	430653611	501c3	$325,000	Early Investigator Award
University of Notre Dame
724 Grace Hall	Notre Dame	IN	46556	350868188	501c3	$325,000	Early Investigator Award
University of Pennsylvania
3451 Walnut St P-221 Frankin Buildi	Philadelphia	PA	19104	231352685	501c3	$325,000	Investigator New to Diabetes Research Award
Dana-Farber Cancer Institute
450 Brookline Avenue	Boston	MA	02215	042263040	501c3	$325,000	Early Investigator Award
University of California San Francisco
3333 California Street Ste 315	San Francisco	CA	94143	946036493	501c3	$325,000	Investigator New to Diabetes Research Award
The Jackson Laboratory
600 Main Street	Bar Harbor	ME	04609	010211513	501c3	$324,977	Early Investigator Award
University of Virginia
1001 N Emmet St	Charlottesville	VA	22904	546001796	501c3	$305,000	Research Career Initiator
Duke University
324 Blackwell St Washington Bldg	Durham	NC	27701	560532129	501c3	$271,031	Research Career Initiator
Joslin Diabetes Center
One Joslin Place	Boston	MA	02215	042203836	501c3	$225,000	Research Career Initiator

Field	Value	IRS element (for citing)
Total501c3 Org	144	Total501c3OrgCnt
Total Other Org	5	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
Lecture Honoraria	7	$47,000
Travel Scientific Conferences	3	$1,953

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 2	Related to Research The American Diabetes Association provides grant funding that aligns with the organizations mission and vision and, supports innovative scientific discoveries that translate to better treatment, healthier lives, and eventual cures. The American Diabetes Association closely monitors the use of all grant funds. Each grantee is required to submit an Annual Progress Report within a 60 day window of each previously committed funding year and is comprised of a scientific and a financial section. Each year of funding after the first is contingent upon approval of the Annual Progress Report and availability of funds. If the complete Report is not received within 90 days after the due date, payments will not be disbursed until all reporting requirements have been met and, the grant may be terminated. After completion of the final year of the grant, a Cumulative Final Report, which includes a scientific and financial section, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible to apply for any future American Diabetes Association Research awards until the obligations for the award are complete. This process is monitored and reviewed by the American Diabetes Association Science and Health Care Management Team for award status and compliance.
Part I Line 2	Related to Camps The American Diabetes Association continues to be the worlds largest provider of camps for children with diabetes to help ensure the wellbeing of families affected by diabetes. The Association provides grants, scholarships and targeted youth programs for persons with diabetes. Each summer, thousands of children have the opportunity to spend time at Diabetes Camp, meeting other children with diabetes and sharing their experiences, challenges, hopes, and dreams. In 2022, the American Diabetes Association hosted 25 camp sessions in 25 states serving 3,000 campers with Type I, and over 3,000 participants at risk for Type 2 diabetes. In addition, more than 1,500 volunteers made camp possible by donating their time and expertise. Camp provides an outdoor recreational experience in which the child for children with diabetes ages 4 to 17 can develop as a person while including informal education about the management of diabetes. Children are carefully supervised by a staff of doctors, nurses, dietitians, and other volunteers and staff. Program Evaluation and outcome measurement provide valuable data to the Association regarding camp programs and how to improve them. An assessment/planning meeting including camp volunteers and staff leadership is held within two months of the conclusion of the camp season. At this time, camp results are evaluated and compared to goals. The strengths and weaknesses of the camp program, opportunities for growth and improvement, emerging issues and needs and the viability of continuation initiation of new programs are evaluated.
Part I Line 2	Related to Education The American Diabetes Association is committed to preventing diabetes. The Diabetes Prevention Program DPP was a major multicenter clinical research study aimed at discovering whether modest weight loss through dietary changes and increased physical activity or treatment with the oral diabetes drug metformin Glucophage could prevent or delay the onset of type 2 diabetes in study participants. The DPP found that participants who lost a modest amount of weight through dietary changes and increased physical activity sharply reduced their chances of developing diabetes. Taking metformin also reduced risk, although less dramatically. The DPPs results indicate that millions of high-risk people can delay or avoid developing type 2 diabetes by losing weight through regular physical activity and practicing healthy eating. Weight loss and physical activity lower the risk of diabetes by improving the bodys ability to use insulin and process glucose. The DPP contributed to a better understanding of how diabetes develops in people at risk and how they can prevent or delay the development of diabetes by making behavioral changes leading to weight loss. These findings are reflected in recommendations from the American Diabetes Association for the prevention or delay of type 2 diabetes, which stress the importance of lifestyle changes and weight loss. Building on the success of the DPP, the Centers for Disease Control and Prevention CDC led National Diabetes Prevention Programs Lifestyle Change Program is an evidence-based lifestyle change program for preventing or delaying type 2 diabetes. The year long program helps participants make real lifestyle changes such as eating healthier, including physical activity into their daily lives, and improving problem solving and coping skills.
Part III Line 1,2	Each year, the American Diabetes Association recognizes the outstanding contributions of individuals in the service of the diabetes community through its National Achievement Awards. These awards are among the Associations most noteworthy and coveted recognition opportunities, celebrating those whose significant contributions to our cause have been national in scope and impact. Past recipients represent individuals or groups that have never faltered in their efforts to improve the lives of all people affected by diabetes.

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Idemnification Gross Up Pmts	Yes (X)	IdemnificationGrossUpPmtsInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (true)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	false	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt
Charles D Henderson Effective May 1
Chief Executive Officer	$455,034	$154,000	$1,301	$194,048	$1,031	$805,414
Charlotte M Carter
Chief Financial Administrative Officer	$329,323	$59,049	$2,389	$31,801	$10,597	$433,159
Robert A Gabbay
Chief Scientific Medical Officer	$481,835	$91,126	$6,922	$48,767	$20,264	$648,914
Alana Seger
SVP Field Revenue Operations	$183,807		$4,320	$7,155	$30,193	$225,475
Sean C McDonough
Senior Vice President General Counsel	$225,511		$2,986	$22,348	$956	$251,801
Nuha El Sayed
Vice President, Health Care Improvement	$200,462		$2,027	$1,133	$876	$204,498
Kelly A Mueller
Senior Vice President, Strategy	$186,857	$7,000	$3,549	$7,586	$1,835	$206,827
Lisa A Murdock
Chief Advocacy Officer	$191,000		$1,840	$13,010	$10,185	$216,035
Laura B Hieronymus
Vice President, Health Care Programs	$188,560		$3,473	$1,172	$10,171	$203,376

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 1a	Payments related to additional pension benefits are grossed up for individual tax reporting purposes.
Part I Line 4b	Charles D. Henderson, Chief Executive Officer, is compensated by the American Diabetes Association and contributed 38,486 to its supplemental 457f retirement plan.
Part I Line 4b	Charlotte M. Carter, Chief Financial Administrative Officer, is compensated by the American Diabetes Association and contributed 18,397 to its supplemental 457f retirement plan.
Part I Line 4b	Robert A. Gabbay, Chief Scientific Medical Officer, is compensated by the American Diabetes Association and contributed 31,939 to its supplemental 457f retirement plan.
Part I Line 4b	Sean McDonough, Senior Vice President General Counsel, is compensated by the American Diabetes Association and contributed 13,686 to its supplemental 457f retirement plan.
Part I Line 4b	Lisa Murdock, Chief Advocacy Officer, is compensated by the American Diabetes Association and contributed 5,499 to its supplemental 457f retirement plan.

Schedule L IRS990ScheduleL

Grnt Asst Bnft Interested Prsn GrntAsstBnftInterestedPrsnGrp (11 entries)

Relationship With OrgRelationshipWithOrgTxt	Cash GrantCashGrantAmt	Assistance PurposeAssistancePurposeTxt
Layla A Abushamat MD
Grant Review Committee Member	$67,500	ADA-Pfizer Fellowship Award
Rachel Goode PhD
Grant Review Committee Member	$199,877	Innovative Clinical or Translational Science New Health Disparities
Anjali Gopalan MD
Grant Review Committee Member	$199,818	Innovative Clinical or Translational Science New Health Disparities
Michelle L Litchman PhD
Grant Review Committee Member	$200,000	Innovative Clinical or Translational Science Health Disparities
Jordi Merino PhD
Grant Review Committee Member	$134,059	Junior Faculty
Rachel G Miller PhD
Grant Review Committee Member	$104,191	Junior Faculty Development
Rochelle Naylor MD
Grant Review Committee Member	$196,259	Innovative Clinical/Translational Science Precision Medicine
Deirdre Kay Tobias DSc
Grant Review Committee Member	$196,859	Innovative Clinical or Translational Science Nutrition
Eva Marie Vivian PharmD PhD
Grant Review Committee Member	$194,500	Innovative Clinical or Translational Science New Health Disparities
Rebekah J Walker PhD
Grant Review Committee Member	$137,836	Junior Faculty Development
Rebekah J Walker PhD
Grant Review Committee Member	$10,000	Student Loan

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Field	Value	IRS element (for citing)
Person	Stephanie Silverman	PersonNm

Field	Value	IRS element (for citing)
Relationship Description	Director	RelationshipDescriptionTxt
Transaction	$973,803	TransactionAmt
Transaction	Government Relations Consulting	TransactionDesc
Sharing Of Revenues	false	SharingOfRevenuesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part IV Line 1	FormAndLineReferenceDesc
Explanation	The American Diabetes Association hired Venn Strategies to provide government relations consulting services. Stephanie Silverman, the Chief Executive Officer of Venn Strategies, served on the Board of Directors of the American Diabetes Association in 2022. This service relationship was reviewed and approved pursuant to the ADAs conflict of interest policy. As a result of this review, Ms. Silverman recused herself from board actions that could be perceived as a conflict of interest.	ExplanationTxt

Schedule M IRS990ScheduleM

Cars And Other Vehicles CarsAndOtherVehiclesGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	497	ContributionCnt
Noncash Contributions Rpt F990	$458,450	NoncashContributionsRptF990Amt
Method Of Determining Revenues	See Part II	MethodOfDeterminingRevenuesTxt

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	46	ContributionCnt
Noncash Contributions Rpt F990	$1,953,343	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Fair Market Value	MethodOfDeterminingRevenuesTxt

Drugs And Medical Supplies DrugsAndMedicalSuppliesGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	35526	ContributionCnt
Noncash Contributions Rpt F990	$1,628,866	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Fair Market Value	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	Yes (true)	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 6	The method of determining noncash contribution amounts is the sales of comparable property and/or opinion of expert to determine the fair market value.
Part I Line 32b	The American Diabetes Association contracts with Charitable Adult Rides and Services, Inc., 4669 Murphy Canyon Road, Suite 200, San Diego, CA 92123, to advertise for donation of vehicles, as well as receive and sell/dispose of the donated vehicles on behalf of the American Diabetes Association.
Part I Line 6,9,20	Column b reports the number of items contributed.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (51 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part III, Line 4	Connected for Life. Today, more than 133 million Americans in the United States have diabetes or prediabetes an invasive, unrelenting, and debilitating disease that spans all ages, geographic areas, and education levels. This chronic disease affects children, the elderly, and minority populations more than others and costs the United States 327 billion each year. It is a global epidemic that contributes to heart disease, stroke, nerve and kidney disease, and vision loss. The American Diabetes Association ADA is the only organization dedicated specifically to the research, education, and advocacy required to improve the lives of over 37 million adults and children in the U.S. with diabetes and the 96 million American adults with prediabetes. For over 80 years, we have been working on the front lines to educate at risk populations protect the rights of people with diabetes at work, school, and other aspects of daily life pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. In recent years, our mission has taken on new urgency, as the COVID 19 pandemic shined a very bright spotlight on diabetes as a public health crisis and on the severe health inequities in our country. The ADA quickly adapted our research focus, resources, programs, and events in service to people living with diabetes and the health care professionals who treat them. In 2022 we continued to support critical research, advocate for affordable health care, and convene the worlds leading scientists to find new ways to tackle diabetes.
Form 990, Part III, Line 4	The moving force behind the work of the ADA is a network of more than 400,000 volunteers, their families and caregivers, a professional society of nearly 12,000 health care professionals, as well as more than 250 staff members. From research labs to the halls of the Capitol, to the offices of health care practitioners to communities nationwide, the ADA is there. We are bending the curve to help people living with diabetes and their families thrive. Why Because our vision is a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. DIABETES RESEARCH. Support the Highest Quality Science. Diabetes is an extremely complex disease, caused by a combination of various genetic and environmental factors that lead to an inability to produce or effectively use insulin. This leads to higher blood glucose blood sugar levels that are eventually high enough to be considered diabetes. The complex number of causes and individuality of each persons diabetes makes finding a cure particularly difficult, and its expected that more than one will be needed. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved care for people with diabetes, resulting in better health outcomes and fewer complications for people with diabetes.
Form 990, Part III, Line 4	The ADA funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our leadership in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the ADA with the framework and early leadership for a formalized diabetes research program. Since the ADA started its Research Program in 1952, we have invested approximately 950 million in innovative diabetes research projects. In 2022 alone, we supported over 140 active research projects and awarded 82 new grants. All these projects were dedicated to progressing the fight against diabetes, and many were led by early career investigators. While we have learned much about diabetes, there is so much left to discover. The primary goals of the ADAs Research Program are to Support the highest quality science across the broad spectrum of diabetes research. Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. Support innovative research with a high potential to have a significant impact for patients with diabetes and move those discoveries into practice.
Form 990, Part III, Line 4	Peer Review Process. One of the factors that sets ADA funded research apart and ensures we are supporting the very best science, is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field peers of the individual submitting the grant. ADA grant applications undergo peer review by three or more volunteer experts who are experienced researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is used to determine which grants to support. Our Research Approach. About two years ago, the ADA refocused our longstanding research program, allowing us to respond more quickly to the most mission-critical needs in diabetes prevention and care, and accelerate innovations ready for expansion. This strategy has been met with much enthusiasm and is growing in size and stature. In addition to our standard grant cycles, in 2022 we partnered with the National Institute of Diabetes and Digestive and Kidney Diseases NIDDK to support next generation researchers in the Centers for Diabetes Translation Research, which aim to improve the translation of research findings related to diabetes prevention, treatment, and health equity.
Form 990, Part III, Line 4	Another 2022 highlight was the Health Disparities Grantee Workshop in Washington, DC, which brought together ADA research grantees for collaboration, project reporting, and exposure to future funding opportunities with NIDDK program officers. This workshop will become our model moving forward as we convene ADA funded researchers to foster cross pollination and a collaborative spirit throughout the field of diabetes. Restarting Pathway. This year we restarted our Pathway to Stop Diabetes Pathway awards program, after a pause due to the COVID19 pandemic. Pathway is a revolutionary five year grant designed to transform diabetes research by attracting innovative scientists, physicians, and researchers through financial support and professional mentorship. The program funds this new generation of scientists 36 to date at the peak of their creativity, providing them with the freedom, autonomy, and resources to discover the next breakthroughs in the field of diabetes. For the first time in Pathways history, in 2022 we diversified our strategy to emphasize translational research while continuing to support basic science projects. Our newest awardees are Anna Kahkoska, MD, PhD, Gillings School of Public Health, University of North Carolina at Chapel Hill, Project Fusing rapid cycle testing and adaptive interventions A scientific pipeline to translate and individualize evidence based psychosocial and behavioral interventions in routine type 1 diabetes care.
Form 990, Part III, Line 4	Lisa Beutler, MD, PhD, Northwestern University Medical School, Project Dissecting sugar induced modulation of gut brain circuits This project seeks to understand how sugar consumption alters the connection between the gut and the brain, and how this may link to obesity and type 2 diabetes. For more information, view our 2022 Research Report. Scientific Sessions. Held annually, Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. The meeting exemplifies the ADAs leadership role in the global diabetes community while providing a critical platform for driving diabetes awareness. In June 2022, the ADA hosted the first hybrid Scientific Sessions from New Orleans, LA, providing a broader reach than ever for the worlds premier meeting on diabetes research, prevention, and care. The enthusiasm was palpable as leading diabetes scientists and health care professionals gathered to present, learn, and discuss the most recent findings and to network with their friends and colleagues in person. Notable presentation topics included COVID19, mental health, adolescent health, and advocacy. The 82nd Scientific Sessions by the numbers 10,000 attendees, 116 countries represented, 193 educational sessions, 1,200 published posters, 80 exhibitors
Form 990, Part III, Line 4	INFORMATION. Saving Lives Through Knowledge. For people affected by or at risk for diabetes, having access to the most up to date tools and resources can literally make the difference between life and death. As a trusted leader, the ADA works to ensure those affected by and at risk for diabetes, their health care team, and the public receive targeted, timely, and accurate information. We deliver resources people can access at any time in multiple formats including our website for consumers diabetes.org, our flagship social media channels, and our professional journals and publications. We focus our efforts on three areas Raising awareness of diabetes as a serious disease. Ensuring patients, providers, and caregivers have tools and resources to effectively treat and manage diabetes. Reaching diverse groups of people who are at risk for or have diabetes, their families, and health care professionals, with the goal of reducing the incidence of diabetes and the impact of complications. Center for Information. The ADAs Center for Information CFI can be reached at 1 800 DIABETES 1 800 342 2383. The CFI marks the first stop for many of our constituents as they start their journey of living with diabetes. The CFI helps to bend the curve every day by providing constituents with information and resources on prevention, nutrition, and diabetes management medications and supplies discrimination issues ADA events assisting professional members and donors and much more. With every touchpoint, our CFI team takes pride in being helpful, respectful, and kind.
Form 990, Part III, Line 4	In 2022, the CFI supported the ADAs mission by Processing nearly 50,000 contacts from constituents, professional members, and others. Collecting 145,606 in donations. Pointing constituents to our digital resources online and epackets and manually processing and mailing packets of literature to those without internet access. Hosting live agent chats to provide constituents with real time access to CFI staff, should questions arise while browsing diabetes.org. Processing 1,206 intakes for our Legal Advocacy team. Providing five percent of all CFI inquiries with information and resources for assistance with diabetes medications and supplies. We continued our working relationships with Novo Nordisk and Eli Lilly to connect constituents who need financial assistance for their insulin directly to the Novo Nordisk Customer Care Center and the Lilly Diabetes Solution Center. In addition, we fostered a relationship with Patient Advocate Foundations Co Pay Relief program to provide direct financial assistance to those who meet eligibility requirements. Digital Engagement. We maintain a strategic suite of digital channels to connect with our consumer and professional audiences while providing the latest diabetes related information and news. From our website diabetes.org to our blog diabetes.org blog to our ever growing presence on Facebook, Twitter, YouTube, and Instagram, the ADA is connected to its constituents 24 7.
Form 990, Part III, Line 4	Our Consumer Website. Our website for consumers, diabetes.org, is widely regarded as the most informative and credible diabetes and nutrition resource online. In 2022, the site had 12.7 million sessions, 18.3 million unique pageviews, and 9.8 million new users. Social Media. The ADAs flagship social media channels continued to grow in 2022 Facebook follower base exceeds 794,000. Twitter following exceeds 143,000. Instagram following exceeds 62,000. LinkedIn continues to be a dedicated marketing communications channel for the professional audience. Our company page has more than 92,000 followers. We also maintain social media communities for health care professionals on Facebook 40,000 followers and Twitter more than 21,000 followers. Our Professional Website. Our website for professionals, professional.diabetes.org, provides the latest resources in diabetes care and research for health care professionals and scientists. Through this mobile friendly platform, the ADA delivers enhanced and customized content as well as access to members only benefits. DiabetesPro is the most advanced collection of diabetes resources available to professionals, providing them with a convenient way to stay informed.
Form 990, Part III, Line 4	Featured content includes News via DiabetesPro SmartBrief, which has over 50,000 subscribers. Diabetes meetings and continuing education opportunities, including the ADAs Scientific Sessions, Clinical Update Conference, and online interactive programs. Clinical practice recommendations, including the Standards of Care in Diabetes. Webcasts and podcasts, including Diabetes Core Update. Journals and books. DiabetesPro Quarterly, our quarterly membership enewsletter, with about 16,000 subscribers. Professional Member Interest Group resources, including our DiabetesPro Member Forum, an online community with more than 18,000 professional users. Research grant information, including funding cycle information and funded research. Diabetes Education Recognition Program ERP information and resources. Professional Education. The primary goal of the ADAs professional education program is to ensure excellent treatment and improve patient outcomes for people with diabetes by providing quality education for all health care professionals on the diabetes management team. The ADA has been accredited to provide continuing education to health care professionals for more than 30 years and is a Joint Accredited Provider. We conduct professional education activities directed toward enhancing knowledge and competence, advancing skills, and apprising health care professionals of the latest developments in diabetes research and clinical practice.
Form 990, Part III, Line 4	Our professional education programs were transformed in 2022 through the utilization of new educational technologies available to enhance learning. The Professional Education Portal provides on demand learning with interactive elements to meet the needs of busy clinicians. Learners can earn certificates of completion from popular programs including Diabetes Is Primary, Making Diabetes Technology Work, Diabetes Education 101 for the Behavioral Health Professional, and Behavioral Health in Diabetes Care. Professional Membership. In 2021 the Professional Membership team began the process of identifying a new database platform that would give the ADA a 360 degree view of all professional constituents and significantly improve the member experience. The new platform, Nimble, went live in November 2022 and provides greater efficiencies for ADA staff and professional users. Going forward, the ADA will be able to offer professional members auto renewal recurring billing. Additionally, Nimble enables visitors to professional.diabetes.org to use other ADA websites with a single username and password. It will also simplify the committee application process along with housing their conflict of interest information in one place.
Form 990, Part III, Line 4	Professional Engagement. In 2022, the ADAs volunteer leadership teams accelerated efforts to provide virtual career development and networking opportunities to our professional constituents. The Professional Membership Interest Groups and the Womens Interprofessional Network of the American Diabetes Association WIN ADA elevated the research being presented at the 82nd Scientific Sessions by recognizing 15 researchers and their abstracts. The Membership Advisory Group showcased this research in a webinar post meeting for those unable to attend. Also at the 82nd Scientific Sessions, the Professional Membership Interest Groups and WIN ADA hosted over 300 ADA members at in person networking events. WIN ADA hosted the first cohort of 25 early to mid career women in their member exclusive professional development course. Our interest groups hosted more than 18 exclusive webinars reaching 1,318 professionals, allowing the groups to foster knowledge and share research updates among members throughout the year. The interest groups and WIN ADA cultivated community through open discussion among like minded professionals with 340 new discussion threads and 534 discussion responses on the DiabetesPro Member Forum. The Focus on Fellows program met in person at the 82nd Scientific Sessions in June. A total of 55 endocrine fellows participated in 25 interactive sessions focused on practical issues such as resumes, career paths, and identifying mentors.
Form 990, Part III, Line 4	The Hands On Webinar Series, a program that provides tips to improve diabetes care, completed its third and final year in 2022. Year three webinars drew an attendance of 2,245. This number was comprised of 1,511 unique professional attendees, more than a third of whom attended multiple sessions. Over the course of all three years, 33 webinars drew a total attendance of 7,422. Education Recognition Program. Since 1986 the ADAs Education Recognition Program ERP has been responsible for evaluating and recognizing diabetes self management education and support DSMES services nationwide. In February 2022, the ERP team, aided by experts and collaborating organizations from across the diabetes community, published the National Standards for Diabetes Self Management Education and Support. These standards, updated every five years, provide guidance and evidence-based quality practice for all DSMES services. This edition includes a focus on embracing cultural differences, social determinants of health, and technological advancements that help improve equitable access to DSMES services for people with diabetes. Throughout 2022, the ADAs ERP team conducted multiple symposiums aimed at helping ERP programs stay updated on the latest advances in diabetes care in alignment with the National Standards for DSMES and ADAs Standards of Care in Diabetes.
Form 990, Part III, Line 4	National Diabetes Prevention Program. The evidence based lifestyle change program known as the National Diabetes Prevention Program National DPP is the gold standard in preventing type 2 diabetes. The ADA is committed to promoting Centers for Disease Control and Prevention CDC recognized lifestyle change programs and improving access for the 96 million Americans with prediabetes, as it is important for everyone who has prediabetes to have an opportunity to prevent or delay type 2 diabetes. As part of this commitment, the ADA has worked with the CDC on a five year cooperative agreement. In 2022, the ADA was granted a one year extension of our work supporting affiliate sites in underserved areas across the country. Through this work, the ADAs DPP team has worked to improve retention in the lifestyle change program through the Dropout Study, which examined why participants do not complete the program and what programs can do to retain them. The findings of this study were presented at the Association of Diabetes Care Education Specialists annual conference ADCES22 in August 2022. Another key component to a successful National DPP lifestyle change program is effective data management and reporting. The ADA prioritizes quality data management and reporting and supports lifestyle change programs and networks by providing a user-friendly data collection and reporting platform called DPP Express. DPP Express not only allows programs to collect and report required data, but also ensures they can make data driven decisions making their programs as effective and efficient as possible.
Form 990, Part III, Line 4	In 2022, the ADA launched functionality that would allow medical billing and claims to be processed directly in the DPP Express platform. No longer are lifestyle change programs required to have a billing department to receive reimbursement for National DPP services. They can now simply submit reimbursable claims in the same place where they collect data. This will provide a cost effective way for smaller community based organizations to bill for DPP services. Diabetes Support in the Community. Through the Pfizer Foundations Health Equity Grant focused on addressing social determinants of health in Black communities, the ADA continues to work with community partners to expand the 10 acre community garden we created in Montgomery, AL, and has established a second community garden in Tampa, FL, to increase access to healthy foods and diabetes support in the community. Community Health Workers. To address the ADAs Standards of Care in Diabetes highlighting the importance of community health workers CHWs in diabetes prevention and management, especially among underserved communities, our National Health Disparities Committee has continued to provide oversight of CHW webinar training development and CHW resources featured on the Community Health Worker section of our website.
Form 990, Part III, Line 4	In 2022, the ADA also continued to partner with the National Center for Farmworker Health as part of a Health Resources and Services Administration-funded grant to deliver professional education opportunities. We also participated in the in-person and virtual forum for Migrant and Community Health, reaching over 1,000 health care professionals and CHWs nationwide. Overcoming Therapeutic Inertia. Despite advances in guidelines and therapies over the last two decades, data show that fewer people with diabetes are achieving an A1C under seven percent. One explanation for this problem is therapeutic inertia a delay or inaction to initiate or intensify therapy when glycemic treatment goals are not met. The ADAs Overcoming Therapeutic Inertia initiative OTI seeks to better understand and address the factors that contribute to therapeutic inertia in diabetes care. If we can overcome therapeutic inertia and manage blood glucose levels early in a persons diabetes journey, as recommended in the ADAs Standards of Care in Diabetes, it will reduce their risk of developing complications and lead to better long term outcomes.
Form 990, Part III, Line 4	In 2022, we Introduced the OTI Certificate Program to empower health care professionals to master strategies that will help patients overcome therapeutic inertia. Developed a new Patient Engagement Toolkit and Practice Improvement Resources, which have been downloaded nearly 3,200 times. Developed infographics for people with diabetes on deintensifying insulin and simplifying diabetes treatment plans. Updated relevant information in the ADA Consumer Guide, which has been accessed by more than 67,000 people to date. Funded a three arm pragmatic randomized control trial to evaluate the effects of physician education regarding therapeutic inertia, with and without proactive outreach by a non-physician clinician, on the achievement of glycemic targets at six months. Developed a practice guide tool for clinicians in small-to-medium sized health care practices to identify and intervene in the care of patients who might be experiencing therapeutic inertia. Supporters Sanofi, Novo Nordisk, Merck, AstraZeneca. Making Diabetes Technology Work. Technology has been a game-changer for diabetes management, and the ADA is dedicated to making these devices, apps, and other tools work harder for the people who need them.
Form 990, Part III, Line 4	Making Diabetes Technology Work focuses on educating health professionals and people with diabetes on how to incorporate these cutting-edge technologies into disease management. With knowledge of available technology, providers can better match their patients with the right tools to reach their blood glucose and other targets. Similarly, people with diabetes can learn how to use diabetes tech and data to streamline their day to day and improve their health outcomes. In 2022, we introduced and enhanced several program resources including nine new elearning modules which attracted over 2,300 participants as well as a webinar and self-assessment program for health care professionals who treat people with diabetes. Supporters Abbott Diabetes Care, LifeScan Mental Health. Diabetes is one of the hardest chronic diseases to manage, requiring people to constantly monitor their blood glucose levels, meals, activities, and mood. Because of this emotional drain, distress and depression are much more common in people with diabetes than people who do not have diabetes. And yet, mental health remains an overlooked topic in diabetes care.
Form 990, Part III, Line 4	To address the mental health burden of diabetes, the ADA maintains a Mental Health Professional Directory a vetted list of 269 licensed practitioners who have specialized training in diabetes related issues. In addition, there are resources for practitioners such as the Diabetes and Emotional Health Workbook and a Mental Health Toolkit to help integrate mental health into diabetes care. These resources were downloaded more than 5,300 times in 2022. Also in 2022 546 mental health professionals completed the updated Diabetes Education 101 for the Behavioral Health Professional elearning course. 479 people completed the new elearning course, Behavioral Health in Diabetes Care, which is for certified diabetes care and education specialists, social workers, and other members of the diabetes care team. Supporter The Leona M. and Harry B. Helmsley Charitable Trust. Womens Health. Up to 10 percent of pregnancies in the U.S. are affected by gestational diabetes every year, a condition that can adversely affect women and their babies later in life. In fact, 50 percent of people with gestational diabetes go on to develop type 2 diabetes and the risk for adverse outcomes doubles for Black and Hispanic women.
Form 990, Part III, Line 4	With the support of Karp Randel, the ADA launched the Womens Health Initiative in 2022 to enhance prevention, appropriate and timely treatment, and education around gestational diabetes and improve outcomes for both mother and child. These efforts included Recruiting health system partners for quality improvement and best practice sharing. Conducting focus groups with community health workers and doulas. Establishing a Scientific Advisory Council to contribute strategic insight and collaborate on education programs. In 2023, we plan to scale the Womens Health Initiative by Facilitating learning collaborative meetings with health system partners to improve baseline data. Conducting focus groups with midwives and women with gestational diabetes. Developing four education modules on gestational diabetes basics, treatments, technology, and health equity. Time in Range. The Time in Range TIR initiative focuses on teaching health care professionals and their patients how to use data from blood glucose meters and continuous glucose monitors CGMs to make treatment and lifestyle decisions. TIR measures the amount of time blood glucose levels are on target between 70 and 180 mg dL for most people. And its more than a number, its a means to improve both the daily quality of life and long term outcomes for people with diabetes.
Form 990, Part III, Line 4	In 2022, with the support of Abbott Diabetes Care and LifeScan, the ADA introduced a suite of new TIR resources 12 Practice Pearl videos, 3 podcasts, 5 webinars, 14 infographics, Gamified case study competition for clinicians. Health care professionals engaged more than 27,000 times with these TIR resources, which covered topics ranging from managing TIR in pregnancy to reducing barriers to diabetes technology for diverse populations. Supporters Abbott Diabetes Care, LifeScan. Diabetes INSIDE. In 2022, Diabetes INSIDE continued to impact the lives of people living with type 2 diabetes and cardiovascular disease by focusing on quality improvement work in the Know Diabetes by Heart initiative with health system partners in the Greater Philadelphia, Mid Atlantic, and Chicago regions that target high risk African American and Latino populations. Through Diabetes INSIDE, primary care and university-based clinic staff attended quality improvement education workshops, as well as collected and analyzed data to identify trends and gaps in care and to monitor for change as we facilitated improvement projects across a wide range of operational, system, and clinical challenges.
Form 990, Part III, Line 4	In 2023, the ADA will be expanding the Diabetes INSIDE Know Diabetes by Heart initiative to additional health system partners. We also plan to expand Diabetes INSIDE quality improvement methodology into new initiatives focusing on improving care for pregnant moms with gestational diabetes in the New York City area, as well as eye care for people living with diabetes in urban and rural Alabama. PUBLICATIONS. Promoting Best Practices. Journals. ADA journals provide more than 40,000 researchers, physicians, and diabetes care specialists with the latest information on scientific research and clinical practice. The ADAs four highly respected professional journals, Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum, publish original research, consensus reports, scientific statements, and more, in addition to supplemental issues including the ADAs clinical practice guidelines the Standards of Care in Diabetes. In 2022, our journals received more than 13 million page views from five million unique users at diabetesjournals.org, and ADA published studies were cited more than 157,000 times, roughly an eight percent increase over 2021. Also this year, Diabetes Care achieved an impact factor of 17.152, the highest mark among journals devoted exclusively to original diabetes research. Diabetes Care and Diabetes are the top two journals publishing diabetes research, ranking second and fourth among the 146 journals in the broader field of endocrinology and metabolism.
Form 990, Part III, Line 4	Standards of Care in Diabetes Guidelines. For more than three decades, the ADA has published the Standards of Care in Diabetes Standards of Care the gold standard of diabetes clinical care guidance. In 2022, the Standards of Care reached more than three million professionals via journal publications and millions more via other ADA programs and channels. This year we worked to improve the processes, increase the methodological rigor, and engage even more experts to produce the 2023 edition, which came out in December 2022. Todays Standards of Care is more evidence based, more accessible, and more actionable than ever, helping clinicians around the world keep up with the rapidly changing health care landscape and drive better care, especially in communities disproportionately impacted by diabetes. Notable updates to the Standards of Care 2023 include Emphasis on supporting higher weight loss up to 15 based on the efficacy of and access to newer medications when appropriate. New recommendations related to sleep health and physical activity in people with diabetes. Broad consideration of social determinants of health in guiding the design and delivery of care. New hypertension diagnosis cut offs hypertension is now defined as a systolic blood pressure 130 mmHg or a diastolic blood pressure 80 mmHg. The expanded role of SGLT2 inhibitor use in preserved and reduced heart failure ejection fraction. The role of finerenone in individuals with diabetes and chronic kidney disease with albuminuria. New lipid management recommendations suggesting lower LDL goals for high-risk individuals.
Form 990, Part III, Line 4	The Standards of Care is available online and in print. We also offer an abridged version for primary care providers, an interactive app, plus continuing education webcasts and a slide deck for professional use. It is a living document, published annually in print and online and updated throughout the year in the form of online annotations and published addenda. Professional Papers and ReportsThe ADA published numerous papers and reports in 2022 to help people living with diabetes thrive, including Automated Insulin Delivery Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Continuous Glucose Monitoring Optimizing Diabetes Care Clinical Diabetes video series. Diabetes Management in Chronic Kidney Disease A Consensus Report by the American Diabetes Association ADA and Kidney Disease Improving Global Outcomes KDIGO. Health Equity and Diabetes Diabetes Spectrum collection. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association ADA and the European Association for the Study of Diabetes EASD. Optimizing the Use of Glucagon like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus Clinical Diabetes video series. Serious Later Risks Associated with Type 2 Diabetes in Adolescents and Young Adults Extended Observations From the TODAY Study Diabetes Care collection
Form 990, Part III, Line 4	Books and Compendia. In 2022, we added the following new editions to our library of professional books and clinical compendia 2022 2023 Guide to Medications for the Treatment of Diabetes Mellitus. John R. White, Jr., PA-C, PharmD Editor. ADA Clinical Compendium Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy. Rodica Pop-Busui, MD, PhD Editor. ADA Clinical Compendium New Evidence-Based Therapies for Complex Diabetic Foot Wounds. Andrew J.M. Boulton, MD, DSc Hon FACP, FRCP and David G. Armstrong, DPM, MD, PhD Editors. ADA Clinical Compendium A Practical Guide to Diabetes Related Eye Care. Thomas W. Gardner, MD, MS Editor. Annual Review of Diabetes 2022. American Diabetes Association. Medical Management of Type 1 Diabetes, 8th Edition. M. Sue Kirkland, MD Editor. Diabetes Core Update Podcast. Diabetes Core Update is a podcast series devoted to presenting and discussing the latest clinically relevant articles from the ADAs four scholarly journals Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum, as well as related content from other sources. In 2022, Diabetes Core Update reached an important milestone in podcasting one million downloads. Listeners can subscribe for free through mainstream podcast platforms or directly through diabetesjournals.org.
Form 990, Part III, Line 4	AWARENESS EDUCATION. American Diabetes Month Todays Diabetes Hits Different. November is American Diabetes Month ADM. Every year, our community comes together to ring the alarm on the diabetes epidemic. For the millions of us who are at risk for it, its a time to get educated, find resources and make sure all those around us are aware of their risk, too. And for the millions of us living with diabetes, its a chance to tell our stories and awaken the world. The theme for ADM in 2022 was Todays Diabetes Hits Different. Todays diabetes hits different. Different than it did even two years ago. Different risk factors and complications. Different communities, but it affects us all. Today, there are different ways to hit back. New technologies to manage diabetes. New public health policies. Better resources to educate ourselves. The ADAs 2022 ADM campaign, encouraged our audiences to share the current reality of diabetes and how they hit back. Everyones journey may be different, but it was time to highlight where weve been and how far weve come. With support from CVS Health, WeightWatchers, and Optum Store, we ran an integrated, multichannel campaign throughout November to help Americans know, share, make, and be the difference in our fight for better health with diabetes. It takes all of us to educate and inspire one another. Todays diabetes hits different, but our community people living with diabetes, those who care for them, and those who support the cause is stronger than ever before.
Form 990, Part III, Line 4	Campaign highlights 3.5M organic social media impressions, 118K social media engagements, 20K views of the ADM homepage, 27 livestreamed events, 612 media mentions 217.8M total potential reach. Focus on Diabetes. Focus on Diabetes FOD addresses the alarming prevalence of eye disease among people with diabetes about 95 percent of which is preventable. In 2022, together with our FOD Visionary Partners, Regeneron and VSP, the ADA increased education and awareness around the importance of routine comprehensive and dilated eye exams to prevent eye disease and vision loss caused by diabetes. Complementing our multi channel consumer awareness campaign were efforts to improve access to screening opportunities and type 2 diabetes risk testing. With the support of the VSP Eyes of Hope Mobile Clinic, community partner Ochsner Health, and local health and eye care professionals, the ADA hosted events in Lafayette and Baton Rouge, LA two communities substantially impacted by diabetes. There we provided no cost dilated eye exams, prescription eyewear, and eye health and diabetes education to 240 at risk constituents.
Form 990, Part III, Line 4	Through our strategic alliances, FOD increased engagement with optometrists, ophthalmologists, and primary care professionals by providing comprehensive education on diabetes related eye diseases. We also leveraged the expertise of a multi disciplinary team to develop FOD Provider Practice Toolkit, Diabetic Retinopathy Eye Health Guide, Eye Care Interprofessional Communication Protocol, A collaboration with and endorsed by the American Optometric Association, American Academy of Ophthalmology, American Society of Retina Specialists, National Eye Institute, and our Visionary Partners, A compendium A Practical Guide to Diabetes Related Eye Care. Supporters Regeneron Pharmaceuticals, Inc., VSP Vision. Know Diabetes by Heart. People living with type 2 diabetes are twice as likely to develop cardiovascular disease as people who do not have diabetes. Launched in 2018, Know Diabetes by Heart is a joint initiative between the ADA and American Heart Association AHA that aims to comprehensively combat the national public health impact of these intertwined diseases. The program turns ADA and AHA practice guidelines into lifelines by providing innovative resources for people with type 2 and targeted education for health care professionals. A total of 158,554 constituents accessed these resources this year.
Form 990, Part III, Line 4	In 2022, Know Diabetes by Heart Hosted 12 live Ask the Experts events for people with diabetes to discuss the relationship between diabetes, heart disease, and stroke. More than 6,000 people joined these sessions. Launched an interactive e learning opportunity to help people with diabetes learn about their risk and take action to prevent heart disease. Engaged with more than 4,000 health care professionals on guideline directed management and therapy. Through the ADAs quality improvement initiative, Diabetes INSIDE, worked with health care systems in Illinois, Maryland, New Jersey, and Pennsylvania to improve health care delivery and clinical outcomes for people with diabetes. Supporters Novo Nordisk, Bayer. ADA Camp. More than 18,000 children are diagnosed with type 1 diabetes every year, a life-changing moment that requires 24/7 control for the rest of their lives. For 74 years, ADA Camp has offered a traditional summer camp experience in a medically safe environment while creating opportunities for children with diabetes to forge life-long relationships, overcome feelings of isolation, and gain self confidence in their diabetes care. After two years of being online, our camps returned in person in 2022. More than 1,700 campers in 27 locations around the country joined in the summer fun, complete with swimming, fishing, kayaking, and the beauty of nature. With help from our partners, we award more than 430,000 in need-based financial assistance annually so even more children with type 1 have the chance to experience ADA Camp.
Form 990, Part III, Line 4	Year after year, the feedback from campers and families is overwhelming 78 of caregivers rated their childs overall health good or excellent, an increase of 22 from before camp. 82 of campers reported less than five days of poor mental health in a 30 day period after camp, a 20 decrease. 45 of caregivers reported that teamwork and communication improved within their family after camp. 41 of campers increased their confidence to try new methods to manage their diabetes. ADA Camp would not be possible without the support of Novo Nordisk Inc., The Leona M. and Harry B. Helmsley Charitable Trust, and Lilly Diabetes. Project Power. Youre never too young or old to lower your risk for type 2 diabetes and its complications. The ADAs Project Power aims to make living healthy second nature for both adults and kids living with prediabetes and type 2. For years, Project Power has aimed to slow the trajectory of childhood obesity and type 2 among youth aged 5 12. Using an outcomes based curriculum, the no cost virtual and in person program promotes making healthy food choices, increasing physical activity, and building family and peer support. In 2022, Project Power for youth grew to serve 27,605 children across more than 40 states.
Form 990, Part III, Line 4	And with the support of our national sponsors, in late 2022 we expanded Project Power to serve the whole family. Project Power for adults over 18 is a 12 month, no cost lifestyle change program that raises diabetes awareness and offers diabetes risk reduction education to people with type 2 diabetes and prediabetes. The program combines interactive lessons with a health coach, small support groups, and tools and resources to empower participants to reach their personal health goals. By 2024, we hope to serve 2,400 constituents in 24 high-risk areas through Project Power because healthy families mean healthy communities and ultimately a healthier world. Project Power was supported in 2022 by CVS, Eli Lilly, OneTouch by LifeScan, Sun Life Financial, and Quest Diagnostics. Diabetes Food Hub. Diabetes Food Hub continues to be a popular destination for people living with diabetes, caregivers, and health care professionals. In 2022, Diabetes Food Hub part recipe database, part grocery list builder, part meal planner, and 100 percent backed by the ADAs nutrition expertise grew by 17 percent. Its enewsletter now reaches over 350,000 subscribers with healthy recipes, cooking tips, and special content to help people cook more meals at home and shop safely in light of COVID19. Video content from our new live cooking class series in partnership with Homemade is now available on the site.
Form 990, Part III, Line 4	Better Choices for Life. Many consumer products and services make health claims, including preventing, managing, or even reversing diabetes and at times those claims can be both questionable and confusing. In March 2021, the ADA officially launched the Better Choices for Life program, designed to help shoppers make better choices while shopping for three product categories food and nutrition, health and wellness, and diabetes management. With its science and evidence based approach, Better Choices for Life provides a simple way to identify products and services that are suitable for people with or at risk for diabetes. Following an extensive evaluation process, companies applying for participation and passing the evaluation may place the Better Choices for Life mark on their packaging. Consumers can look for the mark to understand whether the products claims are supported by scientific evidence and meet the ADAs guidelines. As of 2022, participating companies include CeraVe, Cintas, Crest, Daiya, Egglife, Lavior, Level 2, Lean Cuisine, Listerine, Metamucil, Steel Blue, and Vicks products. What Can I Eat Program. The number one question we hear from people recently diagnosed with diabetes is, What can I eat To address this, in 2015 the ADA launched the What Can I Eat WCIE program to promote and sustain positive behavior changes related to healthy food choices.
Form 990, Part III, Line 4	In 2022 we completed development of the digital WCIE programs nine interactive nutrition education modules and supporting resources. In partnership with Elevance Health, we launched a multi state pilot program in Ohio, Indiana, New York, and Virginia. The program utilized Bento, a food company, to deliver healthy food boxes of items curated by ADA staff. We also trained coaches from community based organizations in local areas to provide program support. Combined, the digital modules and community support resources provide an interactive nutrition education experience, skill building activities, group support, and healthy food boxes in low income communities. Program enrollment began in late 2022. Signature Events. For the first time since February 2020, our signature events were conducted in person across the country, bringing together walkers, riders, and donors to raise critical funds for ADA programs and show their resounding support for all people living with diabetes. We also offered a virtual option, so anyone and everyone could participate. In 2022, 9,986 participants raised a total of 7,191,487 toward our mission. In the lead were Tour de Cure Wine Country, raising over 1.3 million, and Step Out Walk to Stop Diabetes Pittsburgh, which raised 227,590. Another event highlight was the 20th annual Kiss a Pig Gala, held in Bentonville, AR. With over 700 attendees, Kiss a Pig is the most-attended charity gala in the state and the largest ADA gala in the country. The October 2022 event successfully raised over 1.4 million the most in Kiss a Pig history.
Form 990, Part III, Line 4	ADVOCACY. Speaking Up for All People with Diabetes. The ADAs advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Our advocacy work gives people with diabetes, their families, and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state, and national levels. Our primary goals are To increase federal and state funding for diabetes prevention, treatment, and research. To prevent diabetes. To improve the availability of accessible, adequate, and affordable health care. To end the discrimination people with diabetes face at school, work, and elsewhere in their lives. 2022 was a landmark year for diabetes advocacy, with the ADA leading the charge for groundbreaking policies that will improve the lives of the over 133 million Americans living with diabetes and prediabetes. From Capitol Hill to state capitals across the country, our more than 400,000 Diabetes Advocates devoted their efforts to supporting and advancing critical ADA-sponsored legislation and diabetes prevention policies. United in a common goal against this pervasive disease, the ADA continues to work endlessly to implement impactful policy reforms aimed towards bending the curve and promoting a healthier future for diabetes patient communities.
Form 990, Part III, Line 4	Making Diabetes Care More Affordable. Managing diabetes can be financially devastating, dually impacting patients and members of their support system. As more Americans are burdened with rising out of pocket costs, many find themselves skipping care and rationing medications just to make ends meet. While we understand these methods adversely impact treatment plans, this has become the harsh reality for millions of patients struggling with diabetes. In 2022, the ADA worked tirelessly to ensure diabetes treatments are widely accessible and affordable for the American population. Our commitment to advocacy Ushered in the passage of landmark federal legislation limiting the monthly cost of lifesaving insulin to 35 for Americas seniors on Medicare. Yielded policies that capped annual out of pocket costs for seniors on Medicare at no more than 2,000. Ensured premium subsidies for those on Affordable Care Act health insurance plans would continue through 2025. Enacted monthly cost sharing caps on insulin for people with state regulated plans in 22 states, plus the District of Columbia. Prompted Delaware to sign a law capping diabetes equipment and supply costs at a collective 35 per month.
Form 990, Part III, Line 4	Lowering Barriers to Diabetes Technology. Health insurance systems, including Medicare and Medicaid, often have restrictive policies that make it difficult for people to access diabetes-management devices, which have been shown to tremendously improve diabetes outcomes. The ADA recognizes that people who could benefit most from CGMs those with lower incomes, people on Medicaid, and elderly people of color who live in states with the highest rates of diabetes prevalence and mortality are the least likely to have access to this technology. Throughout 2022, the ADA managed to increase access to diabetes technology, and CGMs in particular, at both the federal and state levels. Our concerted advocacy efforts, aimed at the Centers for Medicare and Medicaid, the U.S. Department of Veterans Affairs, and state Medicaid programs and legislatures, resulted in proposed regulations for these federal programs and improvements in Medicaid coverage in more than 10 states. Preventing Amputations. Every three and a half minutes, someone in America undergoes a diabetes-related limb amputation. Sadly, 85 percent of these amputations are preventable, with most occurring among people of color, particularly those with less access to care.
Form 990, Part III, Line 4	In response to these startling amputation statistics, in 2022 the ADA proactively formed an alliance with leading health organizations, professional groups, clinical experts, policymakers, and leaders in the diabetes community, aimed at preventing diabetes related amputations. The Amputation Prevention Alliances APAs overarching mission is to curb the number of amputations among low income and minority individuals with diabetes. Guided by a Clinical Advisory Working Group, the APAs multi-faceted work will include advancing impactful and targeted policy changes, driving clinician awareness of opportunities to prevent amputations, and empowering patients to advocate for the best care. While these reforms will undoubtedly yield a decrease in amputations overall, the ADA will continue to fight to save both limbs and lives. Increased Funding for Diabetes Research and Prevention Programs. Under widespread financial uncertainty, the ADA was successful in increasing federal funding for diabetes research and prevention programs. The National Institutes of Health, the NIDDK, the CDC Division of Diabetes Translation, and the National DPP all received substantial funding increases in 2022. These increases augment vital programs that develop groundbreaking treatments and potential cures for diabetes.
Form 990, Part III, Line 4	Safer Schools for Students with Diabetes. The ADAs Safe at School campaign works to make sure the diabetes management needs of children are met so they are healthy, safe, and able to enjoy the same opportunities as their peers. This campaign maintains a commitment to challenging discriminatory practices and policies on behalf of the nations youth and fostering a healthier learning environment for patients battling the effects of this chronic disease. Historically, New York City Public Schools have failed to meet their legal obligations and provide appropriate accommodations for students with diabetes. Our organization believes students with diabetes deserve to attend school alongside their peers, free from discrimination. In response to these inequities, the ADA filed a lawsuit against the New York City Department of Education and won a settlement in September 2022. Thanks to these efforts, NYC public school students with diabetes now have improved access to diabetes care during the school day and can safely participate in field trips and school sponsored events. We aspire to use this ruling as a model for school districts across the nation.
Form 990, Part III, Line 4	Were Connected for Life. The ADA is the nations leading voluntary health organization fighting to bend the curve on the diabetes epidemic to help people live a better life and thrive until we ultimately find a cure. Diabetes has brought us all together, what we do next makes us Connected for Life. We have a lot to accomplish in 2023, but with our dedicated family of volunteers, advocates, donors, staff, and board members we will continue to make an impact for people with and at risk for diabetes. Learn more about the American Diabetes Association at diabetes.org.
Form 990, Part III, Line 4	Other Program Services revenue reported in Line 4d 1,881,739 relates to the investment in real estate. This investment represents a 1998 donor bequest that restricted the ADA from selling the property for 25 years. A portion of the property is leased to corporations and derives monthly income that is reported in investment income. 108,750 relates to rental income received from tenants of subleased office space.
Form 990, Part VI, Section A, Line 6,7a	The American Diabetes Association has established the voting membership of the ADA as the Voting Members. The Voting Members are comprised of all of the members of the Board of Directors and additional delegates. The Voting Members vote on the election of the organizations governing body each year. No governance decisions are reserved to or subject to approval by the membership.
Form 990, Part VI, Section B, Line 11	IRS Review Process by the Governing Body The American Diabetes Association Board of Directors assigns the Audit Committee the oversight responsibility of the IRS Form 990 and its supplemental schedules prior to completion. After review by management and BDO, the final signed 990 was provided to the ADAs Board of Directors prior to filing with the IRS.
Form 990, Part VI, Section B, Line 12	Managing Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, Officers, Directors, and members of select Board appointed committees and their related subcommittees, journal/periodical editors, and senior staff of the ADA must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes. Through review of the annual disclosures and review of the agendas of the relevant Board ,Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. Based on the situation, senior volunteers and staff presiding over the discussion are responsible to ensure appropriate action is taken for the individual to publicly disclose the conflict, for the individual to recuse him or herself from the discussion, vote or room as appropriate and to ensure the disclosure and action is documented in the minutes of the meeting.
Form 990, Part VI, Section B, Line 15a	Compensation Process Annually, The American Diabetes Association Principal Officers Chair of the Board President, Medicine Science President, Health Care Education and Secretary/Treasurer are responsible for establishing executive compensation consistent with the guidelines approved by the Compensation Committee. The Principal Officers of the ADA use a Compensation Committee, compensation studies and an in dependent consultant to establish the compensation of the Chief Executive Officer and other Key employees. The Chief Executive Officer is responsible for the individual performance evaluations of staff officers and key employees, and establishes the total compensation for key employees subject to the guidelines established by the Executive Compensation Committee. The Executive Compensation Committee develops guidelines for the key employee executive positions listed below following the process described in the IRS intermediate sanctions rules when determining compensation. Specifically, the Committee 1 Is composed entirely of non-employee volunteer leaders who have no familial, business or significant personal relationships with the American Diabetes Association or its executives 2 Assesses the short-term and long-term contribution and performance of CEO and other senior executive employees in meeting very definitive and quantifiable objectives focused on the ADAs mission success 3 Engages an independent compensation consulting firm to compile appropriate comparability data including compensation market information for peers with whom the American Diabetes Association competes for executive talent. 4 The Committee reviews this data in detail for all elements of each executives total compensation, including but not limited to base salary, bonuses, perquisites, fringe benefits, and incentive and deferred compensation arrangements. Upon the executives hire, and at each point in time thereafter at which a new or revised compensation arrangement is under consideration with respect to the executive, the Committee meets before the arrangement is implemented to evaluate the reasonableness of the arrangement by comparing both the arrangement itself and the executives entire compensation package to compensation packages paid by similarly situated organizations for functionally comparable positions 5 Documents, concurrently with its determination, the basis for its determination in the minutes of its meeting These minutes are reviewed, revised if necessary and approved at the following meeting of the Executive Compensation Committee. The process described above was used to establish compensation for the following positions Chief Executive Officer, Chief Development Officer, Chief Financial and Administrative Officer, Chief Scientific and Medical Officer, Chief Operating and Strategy Officer, Chief Advocacy Officer, Senior Vice President and Chief Technology Officer, Senior Vice President of Human Resources, Chief Marketing and Digital Officer. The total compensation of executives at the American Diabetes Association is specifically designed to attract and retain the highest qualified executive talent to fulfill the critically important mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
Form 990, Part VI, Section C, Line 17	Filing Jurisdiction Registration Number Alabama-AL97-256, Alaska-N/A, Arizona-10145, Arkansas-N/A, California-CT81471, Colorado-2002-3003670, Connecticut-5084, District of Columbia-981855, Florida-CH1618, Georgia-CH-001422, Hawaii-N/A, Illinois-CO 01-025537, Indiana-000103829-000, Kansas- 177-257-3SO, Kentucky-45, Louisiana-N/A, Maine- CO-1247, Maryland-102, Massachusetts-029317, Michigan-MICS 10326, Minnesota-N/A, Mississippi- 100000294, Missouri- CO-021-87, New Hampshire-5006, New Jersey- CH-0581900, New Mexico-N/A, New York- 1/30/1965, North Carolina- SL000618, North Dakota-7894, Ohio- 01-0239, Oklahoma- N/A, Oregon- 16402, Pennsylvania- No. 21, Rhode Island-95-233, South Carolina-641, Tennessee-5104, Utah- 6536093-Char, Virginia-N/A, Washington-7664, West Virginia-N/A, Wisconsin- 3020-800.
Form 990, Part VI, Section C, Line 19	The following information is available on the American Diabetes Associations website http//www.diabetes.org Board of Directors, Audited Consolidated Financial Statements, Latest 990 filed, Whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following Current Bylaws, Articles of Incorporation, Conflict of Interest Policy.
Form 990, Part VII, Section A, Line 1a1	The Chief Executive Officer of the ADA is a non-voting member of the Board of Directors.
Form 990, Part IX, Line 11g	Other fees for services include the following Total ExpensesProgram Service ExpensesManagement and General ExpensesFundraising ExpensesProgram consulting fees 12,333,397.00 12,333,397.00 0.00 0.00 Other fees for services 4,317,194.00 2,504,900.00 588,507.00 1,223,787.00 Total16,650,591.00 14,838,297.00 588,507.00 1,223,787.00
Form 990, Part VI, Section B, Line 12c	Research Grants Review Committee Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self reported. The primary considerations addressed in the COI policy and program guidelines are as follows Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co PI, collaborator, subcontracts, etc.. Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review.
Form 990, Part VII, Section A, Line 1-23	Average hours per week is estimated based on meeting attendance and other ADA activities performed throughout the year.
Form 990, Part I, Line 8	Contributions and grants reported on the 2021 Form 990 included forgiveness of Paycheck Protection Program Loans in the amount of 10,321,000.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	American Diabetes Association Property Title Holding Corporation	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2451 Crystal Drive Ste 900	AddressLine1Txt
City	Arlington	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22202	ZIPCd

Field	Value	IRS element (for citing)
EIN	541948004	EIN
Primary Activities	See Part VII	PrimaryActivitiesTxt
Legal Domicile State	VA	LegalDomicileStateCd
Exempt Code Section	501 c 2	ExemptCodeSectionTxt
Public Charity Status	N/A	PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	Association	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Controlled Organization	Yes (true)	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (true)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	false	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	false	SharingOfFacilitiesInd
Paid Employees Sharing	false	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	Yes (true)	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (2 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
American Diabetes Association Property Title Holding Corporation
b	$57,375	Cash
American Diabetes Association Property Title Holding Corporation
s	$1,772,989	Cash

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part II Line 1b	FormAndLineReferenceDesc
Explanation	The mission of the American Diabetes Association Property Title Holding Corp. is to hold title to real property, collect the income therefrom, and remit to the American Diabetes Association.	ExplanationTxt